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The brain adapts to the environment by converting signals of neural activity into altered synaptic 
connections. Long-term reshaping of synapses depends upon neural activity-dependent 
transcription. Activity-dependent transcription, in turn, requires proper packaging of the DNA 
through chromatin regulation. Genes encoding chromatin regulators, transcription factors, and 
synaptic proteins are all associated with autism spectrum conditions and rare intellectual 
disabilities. Such neurodevelopmental conditions may result, then, from a convergence on 
similar molecular pathways, such as activity-dependent synaptic plasticity. Indeed, forms of 
synaptic plasticity such as long-term potentiation/depression and synaptic scaling are known to 
require specific synaptic proteins and transcription factors. However, the roles of chromatin 
regulating proteins in these processes remain poorly understood.  
In part, this is due to the difficulty of examining how chromatin regulators directly guide 
activity-dependent transcription. Chromatin regulators’ direct effects are obscured by the 
commonly used technique of seeking differentially expressed genes from steady-state mRNA 
profiles. Furthermore, compared to transcription factors, chromatin regulators can have fewer 
dramatic gene-specific effects on transcription. Therefore, I used the nascent RNA sequencing 
method BrU-seq and adapted RNA-seq analyses to examine chromatin regulator function in the 
context of activity-dependent transcription associated with synaptic scaling. I then revealed a 
role for the Smith-Magenis Syndrome protein Retinoic Acid Induced-1 (RAI1) as a regulator of 
activity-dependent transcription and synaptic strength in the baseline and low-activity states of 
neurons.  
In a distinct project, I found that neural activity shifts alter not only gene expression, but also 
gene promoter selection. I determined that multi-promoter genes make up nearly 10% of 
expressed genes in neuronal cultures, and that neuronal activity guides differential promoter 
usage in ~10% of them. I also observed differential promoter/transcription start site usage in vivo 
in physiological models of neuronal activity induction and found evidence of excitatory-neuron-
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specific promoter switching. Differential promoter usage predominately predicts altered N-
terminal protein sequences of synaptic and phosphodiesterase family genes. Promoter-specific 
isoforms of the phosphodiesterase PDE2A revealed differential organelle-targeting and altered 
electrophysiological properties, suggesting promoter usage can regulate subcellular protein 
localization and synaptic function. 
In sum, these two projects detail new concepts of activity-dependent transcription and synaptic 





Neuronal activity-dependent transcription is critical for synaptic restructuring 
Changes in behavior during neurodevelopment and in adulthood are mediated by synaptic 
plasticity—the physical modifications of synaptic structures in response to experience. When an 
environmental stimulus activates a set of neurons, cascades of intracellular events lead to long-
term alterations in synaptic connections. This process requires new RNAs to be transcribed and 
translated into the proteins that restructure the synapse (Figure 1-1.) 
The general framework of activity-dependent transcription is as follows.  First, neuronal firing 
leads to an influx of calcium and a series of calcium-response signaling, which reaches the 
nucleus within a neuron. Constitutively-expressed transcription factors such as cyclic AMP-
responsive element (CRE)-binding protein (CREB) and serum response factor (SRF) are then 
activated via post-translational mechanisms, primarily phosphorylation, which subsequently 
initiate the “first wave” of transcription of a set of genes 7 8. The first wave genes encode effector 
proteins such as ARC and BDNF and a number of transcription factors: e.g. FOS, NPAS4, 
EGR1, and C/EBPβ 8. These transcription factors, in turn, activate a “second wave” of activity-
dependent gene expression 8. The second wave genes encode many synaptic and dendritic 
proteins that can modulate neuronal connectivity 9,10, making downstream set of genes an 
intriguing set to analyze what processes are implemented to modulate synaptic plasticity and 
cell-wide adaptations to a changing environment. 





Activity-dependent transcription mediates several forms of synaptic plasticity 
Proper activity-dependent transcription is essential for learning and memory 11, and multiple 
forms of synaptic plasticity, such as synaptic scaling, long-term potentiation (LTP), and long-
term depression (LTD) 12. While LTP and LTD selectively modulate the strength of specific 
synapses in order to tune specific neural circuits, synaptic scaling is a model of a homeostatic 
process to buffer destabilizing shifts in network activity 13-15. That is, in response to a sustained 
increase in neuronal firing rate, neurons decrease, or “scale-down”, the receptivity of the neuron 
to excitatory neurotransmitters. Conversely, global decreases in firing rate cause neurons to 
“scale-up” and increase synaptic efficacy. Synaptic scaling therefore provides a mechanism of 
negative feedback to long-lasting increases of individual synaptic efficacy, which left 
uncompensated, would result in positive feedback loops to produce over- or under-active circuits 
16. Like LTP and LTD, synaptic scaling plays important roles in neurodevelopment, learning, 
memory, and sleep 17-19. Better understanding of learning, memory and sleep will arise from 
unearthing the underlying transcriptional regulation. 
 
 
Chromatin regulation mediates neuronal activity-dependent transcription and synaptic scaling 
Transcriptional regulation is mediated by site-specific transcription factors (TFs) that can recruit 
RNA polymerase II machinery to promoter and enhancer regions. However, there are far more 
TF-specific target sequences across the genome than TFs actually bind, revealing that additional 
layers of regulation are at work. For transcription factors to make contact with the proper 
genomic loci, the DNA must first be organized and the proper loci made accessible by a group of 
proteins called chromatin regulators. In this way, chromatin regulators may prime the DNA for 
activity-dependent transcription and thereby modulate the downstream effects on the synapse 
(Figure 1-1). Supporting this idea, genes encoding chromatin regulators have been found to 
feature disrupted in synaptic plasticity, including the PRC2 histone modification complex 
subunit EED and DNA methyltransferase (DNMT) proteins 20 for LTP/LTD, and for synaptic 
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scaling, TET3 DNA demethylase 21, EHMT1/2 histone H3K9 methyltransferases 22, and 
L3MBTL1 methyl-histone binding factor 23.  
Transcription factors, chromatin regulators, and synaptic proteins are associated with 
neurodevelopmental disorders 
Considering that transcription factors and chromatin regulators are integral to processes of 
synaptic plasticity, including those involved in learning and memory, one would assume that 
disruption of genes encoding these factors may result in aberrant neurodevelopment and brain 
function. Indeed, exome-sequencing studies in the past decade have identified that genes that 
encode transcription factors, chromatin regulators, and synaptic proteins are enriched in cases of 
autism spectrum conditions and neurodevelopmental disorders (NDD) 24,25. Experience-
dependent synaptic restructuring may then be a pathway onto which such neurodevelopmental 
disorders converge (Figure 1-1.) 
This is reflected in recent functional studies that examine the cellular function of NDD-
associated chromatin regulator genes. For example, histone methyltransferase MLL1 and the 
histone demethylase LSD1, both of which are implicated in NDDs, appear to be required for 
optimal activity-dependent transcription 26-28. In addition to these H3K4me regulators, an H3K9 
methyltransferase G9a/GLP 29, an H3K27 demethylase KDM6B 30, L3mbtl, an H3K4me1/2 
reader 23 and engage in activity-dependent transcription and alter synaptic phenotypes.  
 
Improved methods to delineate the roles of chromatin regulators in activity-dependent 
transcription 
Although the link between chromatin regulators and activity-dependent transcription associated 
with synaptic plasticity has been established, there remain several ways in which the field is 
relatively unexplored. Firstly, as activity induction is known to elicit changes at the post-
transcriptional level the analysis of chromatin regulators roles in transcription must be dissected 
from post-transcriptional effects including mRNA decay 31 32 33 and mRNA transport and local 
translation 34. To exclusively examine transcriptional effects, one can use nascent RNA profiling, 
which has been rarely used in previous studies. To develop an approach to examine chromatin 
regulation in the context of bona fide transcription, I applied a nascent RNA sequencing 
4 
 
approach, BrU-seq, in an in vitro model of synaptic scaling (Chapter 2). I next characterized the 
nucleosome binding protein Retinoic Acid-Induced 1 (RAI1) in this process (Chapter 3). I then 
discuss the resulting hypothesis that RAI1 interacts with circadian transcription (Chapter 4).  
In the second branch of my dissertation, I explore the phenomenon of multiple promoter usage in 
the context of activity-dependent transcription (Chapter 5). Neuronal activity has been found to 
initiate differential usage of promoters in a few genes such as the neurexins and BDNF 35-37. 
Activity-dependent transcription encompasses mechanisms such as enhancer activation, 
alternative splicing, A-to-I editing, alternative 3’ end usage, and microRNA expression 31,32,38,39. 
In contrast, profiling the use of alternative promoters has been limited to steady-state mouse 
brains 40, disease states 41, or across developmental timescales 42.  In this dissertation I reveal the 
discovery, through BrU-seq, that alternative promoter usage is a more widespread phenomenon 
in activity-dependent transcription. I validate this process in vivo, using a custom low-RNA input 
sequencing protocol (Appendix A) to profile whole-tissue and excitatory neuron-specific usage 
of promoters using physiological stimuli to model activity-dependent transcription. I demonstrate 
that alternative promoter usage alters the predicted N-terminal amino acids and may alter protein 




Development of the Approach to Analyze Activity-Dependent Transcription 
Introduction 
Several technical obstacles limit our understanding of chromatin regulators’ role in activity-
dependent transcription. RNA-sequencing (RNA-seq) is an unbiased approach that has been used 
to quantify the RNAs isolated from neurons stimulated by neuronal activity 21,43. However, the 
methods by which RNA is conventionally collected and quantitated are not well-suited to 
identify short-term changes in transcription because of the presence of long-lived RNA 
transcripts. Additionally, many protocols for RNA-seq, including single-cell sequencing, do not 
provide information across the entire length of RNA, particularly in the proximal (5’) end of the 
RNA molecule. The 5’ end of the RNA contains biologically relevant information that guides 
RNA stability and encodes protein sequence. These two technological obstacles limit the 
analysis of activity-dependent transcription and its regulation. 
To dissect the precise mechanisms by which these chromatin regulators contribute to 
transcription, accurate monitoring of transcriptional responses is critical. Most prior studies have 
monitored steady-state mRNA levels, using RT-qPCR, cDNA microarray, and mRNA-seq. The 
brain exhibits notorious complexity of post-transcriptional regulation, Therefore, reliance on 
steady-state mRNA measurements may obscure the roles of chromatin regulators in 
transcription, and certainly in the dynamic transcription in response to stimuli.  
To overcome the major limitation of steady-state RNA-seq, we adopted Bromouridine-
sequencing (Bru-seq), a genome-wide profiling technique of nascent transcripts 44,45. We 
prepared primary forebrain-neuron cultures from E18 mouse embryos and allowed them to 






shifts, network activity was elevated by 20 µM bicuculline (BIC, a GABAA-receptor antagonist) 
or suppressed by 1 µM tetrodotoxin (TTX, a sodium channel blocker) for 4 hours. During the 
last 20 minutes of BIC or TTX treatment, we added bromouridine (BrU) to the culture medium 
to label newly synthesized transcripts. We isolated the labeled RNAs using an anti-BrU antibody 
and subjected them to next-generation sequencing (Fig. 2-1A). 
Altered neuronal network activity triggers genome-wide transcriptional changes 
Our Bru-seq data set demonstrated the expected induction of Arc and Fos by BIC (Fig. 2-1B). 
Abundant intronic reads indicate that detected transcripts were recently generated and yet to be 
spliced. Other well-characterized activity-dependent genes such as Npas4, Egr1, Homer1, Tet3, 
and Txnip also showed expected transcriptional induction. Differential gene expression analysis 
of the Bru-seq data using DESeq2 46 revealed widespread transcriptional changes, in which 45% 
of expressed genes (7,592/16,682) were up- or down-regulated by network activity shifts (padj < 
0.05, Fig.1C). BIC increased transcription of 2,908 genes, while TTX did so for 1,820 genes. 
The magnitude of transcriptional induction is higher in BIC treatment compared to TTX (Fig. 2-
1D). To examine the relationship between nascent and steady-state transcriptomes, we compared 
our Bru-seq data to published mRNA-seq datasets of mouse cortical neurons treated with TTX or 
BIC for 4 or 6 hours 21,43 with identical data processing. Our 4-hr Bru-seq results showed a much 
stronger similarity with 4-hr mRNA-seq compared to 6-hr mRNA-seq data (Fig. 2-2B). Thus, 
Bru-seq reliably captures known transcriptional responses to bidirectional shifts in network 
activity. 
Figure 2-1. Genome-wide transcriptional response to bi-directional activity alterations.  
(A) Experimental procedure.  
(B) UCSC Browser views of Bru-seq signals at Arc and Fos. Intronic reads are characteristic of nascent RNA.  
(C) Differential gene expression analysis (DESeq2) reveals widespread transcriptional changes in response to TTX and 
BIC (padj<0.05).  
(D) BIC-response genes show a greater median fold change (Wilcoxon rank-sum test, upregulated genes: p=2.2 x 10−16, 
downregulated genes: p=6.9 x 10−16). Whiskers represent 1.5 times the inter-quartile range (IQR) and the notch 
represents the 95% confidence interval of the median.  
(E) The majority of TTX and BIC response genes are uniquely regulated (70%). 24% of genes are reciprocally 
regulated and 6% are commonly regulated.  
(F) Downregulation of immediate early gene in the TTX condition is captured more sensitively in Bru-seq data 
compared to mRNA-seq data (Yu et al., 2015b). 
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Bru-seq might be a better approach than mRNA-seq to detect downregulation of transcription, 
because persistence of RNAs after transcription does not contribute to Bru-seq signals. Indeed, 
we found significantly larger suppression of Fos, Arc, Bdnf, and Npas4 (4 to 16-fold) by TTX 
treatment in Bru-seq compared to mRNA-seq performed with 4-hr BIC/TTX treatments, in 
which downregulation was less than 2-fold (Fig. 2-1E) 21,43. The magnitude of upregulation in 
response to BIC was smaller in Bru-seq, likely because the early transcriptional induction is 
largely complete four hours after BIC treatment. In a genome-wide scale, Bru-seq allowed us to 
detect transcriptional suppression of numerous genes (BIC; 2,842, TTX: 2,307). These data 
highlight an advantage of the Bru-seq approach to probe mechanisms underlying highly-dynamic 
activity-dependent transcription.  
Based on the behavior of well-defined activity-response genes (Fig. 2-1E), one could assume that 
BIC and TTX trigger reciprocal transcriptional responses. Unexpectedly, only a small fraction of 
activity-response genes (24%, 1,798/7,592) displayed such mirror images between BIC and TTX 
treatments (Fig. 2-1F). 6% (487/7,592) of activity-response genes altered their transcription 
levels in the same direction after BIC and TTX treatments. The remaining majority of genes 
(70%, 5,307/7,592) responded to BIC or TTX uniquely. These data suggest that synaptic up-
scaling and down-scaling involves distinct transcriptional programs.  
Recent studies have reported that different cell types such as astrocytes and neuronal subtypes 
induce distinct sets of genes in an activity-dependent manner 47,48. We sought to assess the 
contribution of various cell types in our datasets. Using immunocytochemistry of a set of cell-
type markers, NeuN, GAD67, GFAP, CD11b, and Olig2, we estimated that our cultures 
comprise 41% excitatory neurons, 11% inhibitory neurons, 33% astrocytes, 15% of cells within 
the oligodendrocyte lineage, and no microglia (Fig. 2-2D-E). We found several non-neuronal 
genes in our dataset, including Thbs1, a synaptic regulator expressed specifically in astrocytes 49. 
We detected enrichment of biological processes specific for both neurons and non-neuronal cell 
types. Intersection of the Bru-seq data with published cell type-enriched genes 50 revealed that 
the majority (> 80%) of activity-response genes do not exhibit cell-type-specific expression (Fig. 
2-2F). Thus, the current dataset represents an aggregate view of transcriptional response 









In sum, we found widespread transcriptional responses to network activity shifts owing to Bru-
seq’s high sensitivity in detecting transcriptional downregulation. Most dynamically regulated 
genes altered by hyperactivity or suppression are unique rather than reciprocal (Fig. 2-1). This is 
interesting given that gene expression studies have focused on reciprocal regulation of genes 
(e.g. Arc, Fos, Homer1, Bdnf) 51. Our results agree with a nascent proteome study on rat 
hippocampal neurons, in which the authors observed unique, common, and reciprocal changes in 
protein synthesis upon TTX and BIC treatments 52. These observations suggest that besides the 
reciprocal transcriptional changes of key factors, distinct transcriptional mechanisms may 
underlie upscaling and downscaling. Interestingly, a small proportion of genes are coordinately 
regulated (e.g. upregulated and downregulated during both upscaling and downscaling), 
suggesting that transitioning from the baseline state may require a common transcriptional 
response.  
 
The dataset of nascent RNA-sequencing is a resource to discover bona fide transcriptional 
changes at a specific timepoint during synaptic scaling or after neuronal activation. It lends itself 
particularly to the examination of motif analysis enrichment in gene regions of interest, e.g. 
Figure 2-2. Bru-seq Validation and Characterization, related to Fig. 2-1.  
(A) Overlap of DE genes in Bru-seq and mRNA-seq. DE genes were called using identical DESeq2 parameters. mRNA-seq 
datasets were obtained from from (Yu et al., 2015b).  
(B) Expression changes of DE-genes upon BIC and TTX treatments in Bru-seq and mRNA-seq (4 hr post-treatment) (Yu et al., 
2015b).  
(C) Comparison of Bru-seq data and mRNA-seq data of 6 hr post-treatment (Schaukowitch et al., 2017).  
(D) Representative immunofluorescence images of the primary forebrain neuron culture (DIV17) with antibodies against NeuN, 
Gad67, GFAP, or Olig2. Nuclei were visualized by DAPI. Scale bar: 20 µm.  
(E) Quantification of cell types. Cell types were determined as follow. Excitatory neurons; NeuN(+), Gad67(−), Inhibitory 
neurons; NeuN(+), Gad67(+), Astrocytes; NeuN(−),GFAP(+), Olig2(−).  33.5%, and Oligodendrocyte lineage cells; NeuN(−), 
Olig2(+). We did not observe cells with CD11b, a microglia marker. Each cell type was calculated as the % of all DAPI+ cells 
and shown as an average of two biological replicates.  
(F) The number of cell type-specific genes and their response to TTX or BIC in the Bru-seq data. Cell type-specific genes were 
obtained from mRNA-seq data of separated cells by immunopanning of P7-P17 mouse cortices (Zhang et al., 2014). Oligo: cells 
within the oligodendrocyte lineage. NR: Non-responsive genes. Both: Genes that respond to both TTX and BIC. 
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promoter regions. Indeed, analysis of TTX and BIC response genes in control cultures 
demonstrated enrichment of specific motifs unique to each gene set. For example, KLF14 is 
enriched exclusively in BIC-downregulated genes. KLF14 is a transcription factor exclusively 
expressed in excitatory neurons (Greenberg single cell) and an imprinted, rapidly evolving gene 
in humans. BIC-downregulated genes have been less well-studied in the role of activity-
dependent gene response, and KLF14 may be a key component in this process. Interestingly, 
BIC-upregulated genes have less strong p-values for enrichment compared to TTX-
downregulated genes, suggesting that downregulation in response to TTX is more carefully 
tuned by site-specific trans factors, while BIC-upregulation may be more dependent on general 
changes in chromatin state.  
What mechanisms could cause transcription to differ between TTX and BIC state? 
Transcriptional machinery itself is a possible avenue by which TTX and BIC states are 
controlled. TFIID is composed of TBP and TBP associated factors (TAFs) of which there are 13 
types53. In our dataset, transcription of TAF1, TAF4, TAF13, and TAF15 are regulated by BIC 
or TTX. In a nascent proteomic study, TAF9 was found to be upregulated by BIC 52. This 
suggests these subunits may be preferentially found in Pol-II complexes in TTX and BIC states. 
Co-immunoprecipitation of Pol II and its TFIID subunits from cultured excitatory neurons 
stimulated with TTX or BIC could be analyzed through Western blotting or mass spectrometry to 
see if there is a significant change in TFIID complex composition. TAF proteins have differential 
effects on transcription, including transcription of inducible genes at baseline and the return of 
inducible genes to baseline levels in Drosophila models 53,54. This suggests TAF proteins may 
have interesting roles in the inducible gene expression in neurons. Another approach may be to 
overexpress or knockdown expression of these factors and screen for changes in synaptic 
properties or transcription of key genes. Indeed, mutations in TAF proteins TAF1 and TAF8 
have been shown to be associated with neurodevelopmental disorders while having limited 
impact on non-neuronal transcription, suggesting brain-specific roles for these genes that may 




RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling 
Loss of RAI1 function is associated with Smith-Magenis Syndrome 
RAI1 is the primary gene implicated in Smith-Magenis syndrome (SMS, MIM: 182290) and 
Potocki-Lupski Syndrome (PTLS, MIM: 610883, Table 1). SMS is characterized by low 
intellectual quotient (IQ), delayed motor and speech abilities, altered sleep cycles, obesity, 
hypotonia, specific craniofacial characteristics, and self-injurious behaviors such as face-
slapping and polyembolokoilamania 57,58. SMS is most commonly associated with heterozygous 
microdeletions of chromosome 17p11, which span the minimal 1.5 Mb region that contains 13 
genes including RAI1 59. Truncation and missense mutations in RAI1 have been reported in 
individuals with prototypical SMS, implicating RAI1 as the major gene contributing to the 
neurodevelopmental and behavioral symptoms (reviewed in 60,61).  
Interestingly, duplication of the same 17p11.2 interval containing RAI1 is associated with PTLS 
62. PTLS and SMS share similar symptoms of low IQ and hypotonia. However, in contrast to the 
obesity and self-injurious behavior in SMS, individuals with PTLS are characterized with 
reduced body weight, hyperactivity and autistic behaviors. While individuals with SMS 
experience daytime sleepiness and nighttime awakenings, individuals with PTLS display sleep 
apnea 61,63. The 125 kb duplication region common to all PTLS cases overlaps only with RAI1, 
strongly supporting a causative role of RAI1 duplication in PTLS 64.  
 
RAI1 has also been genetically associated with other autism-related conditions 65 and 
schizophrenia 66. RAI1 protein levels were altered in post-mortem prefrontal cortex from patients 
with schizophrenia, bipolar disorder and major depression 67. In addition, RAI1 expression levels 
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were shown to be commonly decreased in multiple intellectual disability syndromes that are not 
directly associated with RAI1 mutations. These include brachydactly with mental retardation 
(BDMR, MIM: 600430), caused by deletion of HDAC4-containing chromosome 2q37 region 68, 
and 2q23.1 deletion syndrome (MIM: 156200) 69. This suggests RAI1 might be a downstream 
effector in other neuropsychiatric conditions. 
 
Mouse models with syntenic microdeletions or microduplications, Rai1 knockout, or Rai1 
overexpression, recapitulate learning disabilities, metabolic disorders, craniofacial features, 
and/or sleep abnormalities observed in SMS or PTLS individuals 70-75 2,76. These observations 
strongly suggest that RAI1 exerts an evolutionarily-conserved, dosage-sensitive role in 
neurodevelopment. RAI1 is expressed in the brain throughout embryonic and adult brain 2,76. 
Studies in mouse models and human patient cells have uncovered roles of RAI1 in gene 
expression, neuronal structure, and behavior 2,70,74,77,78. 
However, little is known about RAI1’s roles in activity-dependent transcription and synaptic 
plasticity. Because of the described relevance to neurodevelopment, we then used the Bru-seq 
approach to uncover a role for RAI1 in this transcriptional program.   
RAI1 suppresses the TTX-induced transcriptional program in resting networks   
We developed an anti-RAI1 antibody and confirmed that RAI1 protein was present in virtually 
all MAP2-positive neurons and primarily localized to the nucleus with subtle signals in the soma 
(Fig. S2A). We found lower RAI1 levels in non-neuronal (MAP2-negative) cell nuclei (Fig. 
S2A), highlighting its important role in neurons. Widespread presence of RAI1 in neurons is 
consistent with previous studies 2,79(Fig. S2B-C).  
Having established nascent transcription profiling in neural ensembles and presence of RAI1 in 
the culture, we sought to test if RAI1 has any roles in synaptic scaling and transcriptional 
responses to altered neuronal activity. We knocked down (KD) Rai1 in primary cortical cultures 
using lentiviral vectors (LV) carrying Rai1- or scrambled shRNAs (sh-Ctrl). To minimize impact 
of RAI1 loss on network connectivity, we delivered LV shRNA at DIV14, a time by which 




Figure 3-1. Rai1-KD alters transcription of TTX-response genes at the baseline.  
(A) Validation of Rai1-KD with Western blot. Mouse forebrain neuron cultures were transduced with lentivirus expressing sh-
Rai1 or sh-Ctrl for three days.  
(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl v sh-Rai1, padj<0.05) after Vehicle treatment.  
(C) Many Rai1-KD DE-genes are TTX and BIC-response genes.  
(D) The fold changes of TTX- and BIC-response genes by Rai1-KD at baseline. Note that Rai1-KD cultures displays 
transcriptional profile similar to TTX-treated normal cultures. r= Spearman’s rank correlation coefficient. 
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days post-LV infection (Fig. 2A). We then modulated network activity of LV-treated cultures by 
applying TTX or BIC for four hours and carried out Bru-seq as described above.  
We initially tested if Rai1-KD alters nascent transcription in control “resting” neuronal cultures 
with stable basal levels of activity. DESeq2 analysis revealed 122 differentially expressed (DE) 
genes: 104 downregulated and 18 upregulated following Rai1-KD (padj <0.05, Fig. 3-1B, Table 
S3). The greater number of downregulated genes is consistent with previous studies 2,58. A 
majority of genes altered by Rai1-KD at baseline were BIC- or TTX-response genes (Fig. 3-1C). 
To further characterize the relationship between RAI1 deficiency and BIC- or TTX-response 
genes, we examined how individual genes behave upon Rai1-KD. We found a clear positive 
correlation between the normal transcriptional response to TTX and the transcriptional 
impairment by Rai1-KD at baseline (Spearman rank correlation coefficient r=0.53, t-test 
p=2.2x10-16, Fig. 3-1D, left panel). BIC-response genes showed no correlation with Rai1-KD 
(Fig. 3-1D, right panel). The group of genes that respond reciprocally to TTX and BIC (Fig. 1F) 
showed a similar correlation as there was with all TTX-responsive genes (Fig. 3-2D). When we 
removed all DE genes upon Rai1-KD from the plot, the correlation remained significant (r=0.52, 
p=2.2x10-16, Fig. 3-2E), suggesting that the DE genes are not the sole driver for the observed 
correlation. We also analyzed the published mRNA-seq of the Rai1-KO cortices 2 and found a 
similar trend in expression pattern of the TTX- and BIC-response genes in vivo (Fig. 3-2F). 
These data show that RAI1 deficiency shifts the transcriptional profile towards the TTX-treated 










RAI1 deficiency promotes synaptic upscaling 
Chronic perturbation of neuronal activity by BIC or TTX induces decreases and increases in 
synaptic strength, which respectively, underlie homeostatic synaptic downscaling and upscaling 
13-15. Given that Rai1-KD shifted the nascent transcriptome towards the TTX-like state, we asked 
whether Rai1-KD would similarly shift excitatory synapse function towards a state similar to 
synaptic upscaling. We used sparse transfection of DIV12-14 hippocampal cultures with either 
Rai1- or scrambled shRNA, and recorded miniature excitatory postsynaptic currents (mEPSCs) 
from transfected pyramidal-like neurons 48 hours later. If Rai1-KD induces synaptic 
strengthening in a cell-autonomous manner, we would expect to see a rightward shift in the 
distribution of mEPSC amplitudes as is observed during synaptic upscaling following chronic 
activity suppression with TTX. Consistent with this idea, we found that the expression of two 
distinct shRNAs targeting Rai1 mRNA each induced a significant increase in baseline mEPSC 
amplitude (Fig. 3-3A-B), without significantly altering mEPSC frequency or decay time (Fig. 3-
3C-D and Fig. 3-4A-E). Moreover, Rai1-KD induced a clear rightward shift in the cumulative 
probability distribution of mEPSC amplitudes relative to control neurons (Fig. 3-3E and Fig. 3-
4E), an effect that was significantly (albeit partially) rescued by expression of RNAi-resistant 
RAI1 (F (2, 41) = 4.452, p = 0.017.  sh-Ctrl, sh-Rai1 #1 and Rescue: n = 15, 15 and 14, sh-Ctrl 
vs. sh-Rai1 #1; p=0.068, sh-Rai1 #1 vs. Rescue; p = 0.0359, sh-Ctrl vs. sh-Rai1 #2: n = 14-13, p 
= 0.0012, Fig. 3A-E).  The shift in distribution of mEPSC amplitudes with Rai1-KD bears a 
Figure 3-2. RAI1 protein is expressed primarily in neuronal nuclei and supporting figures to Figure 3-1. 
(A) Sub-cellular RAI1 localization was assessed by immunofluorescence in the mouse forebrain neuron culture (DIV17) using an 
anti-RAI1 antibody. RAI1 displayed nuclear localization in excitatory and inhibitory neurons. RAI1 did not show any sub-
cellular or sub-nuclear localization by TTX and BIC treatments for 4 hr. We obtained similar results at other time points (15 
minutes, 1 hr, 2 hr, 8 hr, and 24 hr, data not shown).  
(B) Rai1 mRNA levels in neurons and non-neuronal cells of the adult mouse cortices (Zhang et al., 2014).  
(C) Rai1 mRNA levels in single cell mRNA-seq data of mouse visual cortex (Basic et al., 2016).   
(D) Transcription of reciprocal genes in the Rai1-KD culture at baseline show a positive correlation with TTX-treated 
transcriptome and a negative correlation with BIC-treated transcriptome of the normal culture.   
(E) Premature TTX-response of Rai1-KD culture is still observed after excluding the RAI1-dependent genes at baseline.  
(F) Expression of TTX- and BIC-response genes in the pan-neuronal Rai1-knockout (KO) cortex. mRNA-seq data were obtained 
from 3 week-old Rai1flox/flox: Nestin-Cre and control mice (Huang et al., 2016). Fold changes in KO vs Control mice were 
calculated using the RPKM values. The Rai1-KO mRNA expression shows a trend of TTX-treated transcription states. 
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striking similarity to changes in mEPSC distributions following chronic TTX treatment (Fig. 3-
3F), although Rai1-KD did not shift mEPSC amplitudes to quite the same degree as TTX. An 
increase in surface expression of AMPA receptors (AMPARs) at synapses is a signature of 
synaptic upscaling following activity suppression. Consistent with previous observations, surface 
expression of the GluA1 AMPAR subunit at PSD-95-labeled excitatory synapses is significantly 
increased following chronic (24 hr) TTX treatment (sh-Ctrl Vehicle vs. TTX: n = 13-12, p = 
0.0019, Fig. 3-3G); likewise, we found a similar enhancement of surface GluA1 at synapses 
following 72 hr Rai1-KD (sh-Ctrl vs. sh-Rai1: n = 6-6 p = 0.0065, Fig. 3-3G). Together, these 
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results suggest that reduced Rai1 expression induces functional changes in excitatory synaptic 
function that mimic synaptic upscaling induced by activity suppression.    
Two scenarios could explain the increase in mEPSC amplitude by Rai1-KD accompanied by 
TTX-like transcription in resting neurons. The first possibility is that Rai1-KD suppresses 
network activity, which in turn, indirectly promotes a TTX-like transcriptional program and 
synaptic upscaling. An alternative possibility is that release of RAI1-mediated suppression of a 
TTX-responsive transcriptional program directly upscales synapse function. To distinguish these 
possibilities, we measured ongoing basal network activity of control hippocampal cultures and 
Rai1-KD cultures using 60 channel microelectrode arrays (MEAs, Fig. 3-4F-G). On DIV 11, we 
transduced the cultures with LV control- or Rai1-shRNA and recorded network activity on DIV 
14. We used semi-automatic principal component analysis to sort individual neuronal units 
(Figure 3-4H-K). If the changes in mEPSCs and transcriptional dynamics are an indirect effect 
secondary to Rai1-KD suppressing network activity, then we would predict a marked decrease in 
neural firing.  Contrary to this prediction, Rai1-KD did not suppress firing in the network, and 
instead led to 1.4-2.1-fold increase in spontaneous firing rate compared to scrambled shRNA 
Figure 3-3. Rai1-KD increases the synaptic efficacy at baseline activity condition.  
(A-D) Example traces and mean ± SEM mEPSC amplitude (B), frequency (C), and decay time (D) for cultured rat 
hippocampal primary neurons recorded after transient transfection (48 hr) with either non-targeting shRNA (sh-Ctrl), Rai1 
targeting shRNA or sh-Rai1 #1 with RNAi resistant RAi1 expressing construct (Rescue) at DIV12-14. Scale bar, 10 pA, 75 ms 
(sh-Ctrl, sh-Rai1 #1 and Rescue, n = 15, 15 and 14, respectively)  
(E) Cumulative distribution of mEPSC amplitudes of sh-Ctrl (left), sh-Rai11 (middle) or Rescue (right) transfected neurons.  
(F) Cumulative distribution of mEPSC amplitudes of sh-Ctrl transfected neurons treated by either vehicle or 1 µM TTX (left) 
and sh-Ctrl or sh-Rai1 transfected neurons (right).  
(G) Representative images of surface GluA1 (sGluA1, fire), PSD-95 (green) and sGluA1 & PSD-95 (merge) of sh-Ctrl and sh-
Rai1 infected dendrites. Scale bar 10 µm. Bar graph of mean sGluA1 signal intensity in PSD-95 positive regions for vehicle or 
TTX (n = 13-12), and sh-Ctrl or sh-Rai1 (n = 6-6) treated neurons. All bar graphs represent mean ± SEM. One-way ANOVA, 
followed by post-hoc Fisher’s LSD test were performed for B-D and unpaired Student’s t-tests were performed for G. *p < 
0.05, **p < 0.01, ***p < 0.001  
(H) Prototypical local field potential recordings from individual electrodes exhibiting a single neuronal unit from cultures 
transfected with: sh-Ctrl, sh-Rai1 #1 or sh-Rai1 #2 lentivirus. Scale bars are 25 ms and 10 µV, 25 µV or 40 µV for sh-Ctrl, sh-
Rai1 #1, and sh-Rai1 #2, respectively.  
(I) Firing frequency of individual neuronal units recorded from cultures transfected with sh-Ctrl, sh-Rai1 #1, or sh-Rai1 #2 (n = 
115, 140, and 131, for sh-Ctrl, sh-Rai1 #1 or sh-Rai1 #2, respectively). Statistical comparisons were made using Kruskal-
Wallis test followed by post-hoc Dunn’s multiple comparisons test. K-W: 9.358,  p value 0.0003. Bar graphs represent mean ± 
SEM.  Significance in Dunn’s test indicated by **p < 0.01, ***p < 0.001. 
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(Fig. 3-3H-I, Kruskal-Wallis test: 9.36, p = 0.009; Dunn’s post-hoc test: sh-Ctrl vs sh-Rai1 #1 p 
= 0.053; sh-Ctrl vs sh-Rai1 #2 p = 0.010) likely due to enhanced excitatory drive that 
accompanies Rai1-KD-mediated synaptic strengthening. These data thus support the second 
explanation, where RAI1 suppresses a TTX-responsive transcriptional program and synaptic 





Figure 3-4. Electrophysiology of Rai1-KD cultures at baseline, related to Fig. 3-3.  
(A-D) Example traces and mean ± SEM mEPSC amplitude (B), frequency (C), and decay time (D) for cultured rat 
hippocampal primary neurons recorded after transient transfection (48 hr) with either non-targeting shRNA (sh-Ctrl) or 
Rai1-shRNA (sh-Rai1 #2) at DIV12-14. Scale bar, 10 pA, 75 ms (sh-Ctrl, sh-Rai1 #2; n =14-13)  
(E) Cumulative distribution of mEPSC amplitudes of sh-Ctrl (solid) and sh-Rai1 #2 (dot)-transfected neurons. All bar 
graphs are represented as mean ± SEM, and unpaired Student’s t-tests were performed. **p < 0.01  
(F) Representative macroscopic image of a 60 channel multielectrode array (MEA) chip.  
(G) Brightfield micrograph of dissociated hippocampal neurons growing on an MEA showing multiple cells near 
electrodes.  
(H) Representative local field potential trace exhibiting multiple neuronal units. Each red asterisk indicates a single 
detected spike.  
(I) Representative principal component plot of spike sorting algorithm. Cyan dots represent spikes that were included in 
the current neuronal unit, red dots represent spikes that were excluded and subsequently resorted for identification of other 
neuronal units.  
(J) Resulting neuronal unit identified from spikes sorted in C. Red foreground trace represents mean spike waveform, 
individual spike waveforms shown in grey.  
(K) Spikes that were excluded from Neuronal Unit 1 (red dots from C) were further sorted to identify additional neuronal 
units. Blue line represents the mean waveform of the excluded spikes, grey lines represent individual spike waveforms. 
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RAI1 promotes transcriptional responses triggered by reductions in network activity  
Having uncovered that RAI1 was essential to suppress the TTX-associated transcriptional 
program under basal activity conditions (Fig. 3-2), we next tested if Rai1-KD has any impact on 
transcriptional responses to TTX and BIC treatments. By calculating fold-changes of 
transcription, we found that Rai1-KD led to a significant impairment of transcriptional response 
to TTX, while transcriptional responses to BIC were slightly weaker only for downregulation 
(Fig. 3-5A). However, in contrast to the 130 genes transcriptionally altered at baseline, DESeq2 
comparing Rai1-KD and control revealed only 8 DE genes after TTX or BIC treatment, 
indicating that the impact of Rai1-KD is greater in resting neurons compared to drug-treated 
neurons (Fig. 3-5B).  
We then sought to determine if the strongly-impaired transcriptional response to TTX (Fig. 3-
5A) was due entirely to the TTX-like transcriptional state of Rai1-KD culture at baseline or if 
RAI1 also contributes to the transcriptional response to TTX. Differential gene expression 
analysis by DESeq2 relies on an arbitrary statistical significance cutoff to report differentially 
expressed genes. However, the individual gene plot in the baseline condition revealed a global 
transcriptional trend resulting from minor changes in many genes including those that failed to 
achieve statistical significance (Fig. 3-6E). To define the impact of RAI1 loss after TTX- and 
BIC-treatment, we therefore used this individual-gene plot approach. We found that, after TTX 
treatment, the transcriptional changes of TTX-response genes in Rai1-KD cultures inversely 
correlate with their changes upon TTX treatment in the control condition (Fig. 3-5C, left panel, 
Spearman rank correlation coefficient r=0.32, t-test p=2.2x10-16). This result indicates both 
incomplete downregulation and upregulation upon TTX treatment independent of the impact of 
Rai1-KD in the resting state. The same TTX-response genes did not show obvious changes after 
BIC treatment of Rai1-KD culture (Fig. 3-6A, left panel). Transcription of the BIC-response 
genes did not show changes by Rai1-KD under any condition (Fig. 3-5C, right panel and Fig. 3-
6A, right panel).  Thus, Rai1-deficiency leads to a subtle yet widespread impairment of the 
transcriptional response to TTX but not to BIC. Taken together, these results led us to conclude 










Figure 3-5. RAI1 positively regulates the transcriptional response to TTX.  
(A) The fold changes of TTX- and BIC-response genes in cultures treated by sh-Ctrl or sh-Rai1 (Wilcoxon rank-
sum test). Whiskers represent 1.5 times IQR and the notch represents the 95% confidence interval of the median.  
(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl v sh-Rai1, padj<0.05) after TTX, Vehicle, or 
BIC treatment.  
(C) Incomplete downregulation and upregulation of genes by TTX (left) but not by BIC (right) in Rai1-KD 
cultures. “r” and “p”: Spearman’s rank correlation coefficient and p values.  
(D) RAI1-dependent gene ontologies (Biological Process, padj <0.005) discovered by RNA-Enrich (Lee et al., 
2016) and filtered by ReviGO software (Supek et al., 2011).   
(E) RPKM values of four Sig-genes downregulated by Rai1-KD in the TTX-treated condition. The Sig-genes 
represent “neurotransmitter transport” (padj =9.3x10-8), the top-downregulated Biological Processes. The 
remaining Sig-genes are shown in Figure 3-6. Note slight but consistent inter-replicate changes upon Rai1-KD. 
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Figure 3-6. Impact of RAI1 loss on transcription after TTX- or BIC-treatments, related to Fig. 3-5.  
(A) The fold changes of TTX- and BIC-response genes by Rai1-KD after the opposite treatment (BIC or TTX, 
respectively).  
(B) RPKM values of Bru-seq data are represented for Sig-genes of “neurotransmitter transport”, which was downregulated 
by Rai1-KD in the post-TTX condition (padj: 9.3 x 10−8). Note consistent reduction in RPKM across biological replicates in 
Rai1-KD culture in the TTX-treated condition. 
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We then explored biological implications for the impaired transcriptional response to TTX. We 
used RNA-Enrich, a gene ontology algorithm, which takes into account weaker changes in gene 
expression 80,81. Notably, RNA-Enrich identified many more RAI1-dependent biological 
processes after TTX treatment than vehicle- or BIC treatments (45 in TTX-, 3 in vehicle-, and 7 
in BIC-treated cultures, Fig. 3-5D). The padj values were evidently lower in the post-TTX 
transcriptome data compared to BIC conditions. The RAI1-dependent gene ontologies after TTX 
treatment represent synapse-related processes, whereas those altered in the BIC and vehicle-
treated conditions show fewer ontologies directly relevant to neuronal activity (Fig. 3-5D). RNA-
Enrich provides the identity of signature genes, called Sig-genes, which significantly contributed 
to the enrichment of an ontology 80,81. As expected, Sig-genes for the synapse-related ontologies, 
including Ngf, Syn3, Cacna1b, Rab3a, showed mild yet reproducible transcriptional changes 
upon Rai1-KD (Fig. 3-5E and Fig. 3-6B).  
RAI1 dissociates from chromatin in response to activity changes 
The activity state-dependent requirement of RAI1 in regulating transcription led us to 
hypothesize that activity shifts of neuronal network might alter RAI1 distribution on chromatin. 
To test this, we performed chromatin immunoprecipitation coupled with deep sequencing (ChIP-
seq) for RAI1 in DIV17 neuronal cultures treated for 4 hr with TTX, BIC, or Vehicle. We 
observed clear RAI1-binding at the promoters of RAI1-dependent genes such as Homer1 and 
Per2 (Fig. 3-7A). The control ChIP using Rai1-KD cultures showed no such events, 
demonstrating the specificity of ChIP experiments. RAI1 binding was much weaker in TTX- or 
BIC-treated cultures (Fig. 3-7A). Consistent with visual observations, peak calling identified 
only 13 RAI1 peaks across all three Rai1-KD ChIP-seq samples (not shown), and they were 
removed from all subsequent analyses.  In control cells, 6,065 RAI1 peaks were found in the 
Vehicle-treated condition, and a drastic reduction of RAI1 peaks upon TTX- (98 peaks) and the 
BIC- (1 peak) treatments (Fig. 3-7B). Variable ChIP efficiency or sequencing depth cannot 
explain the scarce peaks in TTX- and BIC- conditions, because we spiked in Drosophila 
chromatin and fly-specific H2Av antibody and ensured consistent sequencing depth and ChIP 
efficiency across the samples (Fig. 3-8A). Neither RAI1 protein levels (Fig. 3-8B) nor did 
nuclear localization (Fig. 3-2A) change after TTX- or BIC treatments. Thus, activity alterations 
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largely release RAI1 from chromatin, which is remarkably consistent with the greater number of 





RAI1 directly controls activity-responsive gene transcription in stable networks 
Intersection with Bru-seq data revealed that that RAI1-bound genes are much more likely 
responsive to network activity shifts than RAI1-free genes (p < 2.2x10-16, Chi-square test, Fig. 3-
7C and Fig. 3-8C). Consistently, RAI1-bound genes associated with plasticity-related ontologies 
including synapse organization (Fig. S5D). Most of these peaks are present at the promoters in 
the resting culture (Fig. 5B) and exhibited a bimodal distribution around transcription start sites 
(TSS) that harbor H3K4me3 (Fig. 5D). Binding motifs of activity-dependent transcription factors 
(TFs), e.g. MEF2A, AP1, LHX2, CREB3L, are enriched in RAI1-bound promoters (Fig. 3-7D). 
RAI1 also occupied intra- and intergenic regions. In the resting culture, 54% of such non-
promoter regions overlapped with DNAse-I hypersensitivity sites (DHS) identified in 8-week old 
mouse whole-brain 82, and the rest were DHS-free (Fig. 3-7B). Some RAI1-bound DHS 
coincided with H3K4me1 or H3K27ac 83, indicating that these elements are likely transcriptional 
enhancers (Fig. 3-7B, see methods). A substantial fraction (67%) of RAI1 peaks overlapped with 
previously reported RAI1 peaks in adult mouse brain 2 with common TF motifs (Fig. 3-8E-F). In 
sum, these analyses show that RAI1 preferentially engages activity-responsive promoters with 
H3K4me3 in neural networks with stable basal levels of activity.  
Are the RAI1-dependent genes found in Bru-seq direct targets of RAI1? Of the genes up- or 
down-regulated by Rai1-KD, RAI1 occupied 40/122 genes (30%) in the baseline culture, which 
is significantly higher than the genomic average (p < 0.05, Chi-square test, Fig. 3-8G). The direct 
Figure 3-7.  Activity-dependent chromatin engagement of RAI1.  
(A) UCSC Browser view of RAI1 ChIP-seq signals at Rai1-dependent genes Homer1 and Per2.  
(B) Number of RAI1 peaks in TTX-, Vehicle-, or BIC- treated cultures.  
(C) RAI1-bound promoters are enriched for activity-response genes (Chi-square test, p = 2.2e-16).  
(D) Bimodal RAI1 distribution around TSS. H3K4me3, H3K4me1, H3K27me3, and H3K27ac levels are plotted 
as controls (see methods).  
(E) Activity-dependent TF motifs enriched in RAI1 peaks.  
(F) RAI1 directly up- and down-regulates the transcription in the naïve culture (See Fig. S10E for a statistical 
enrichment).  





targets of RAI1 can be up- or down-regulated upon RAI1 loss. Of the 18 genes upregulated by 
Rai1-KD, RAI1 binds to 10 promoters (Fig. 3-7F), while RAI1 occupies 29/104 genes 
downregulated by Rai1-KD. These results support the idea that RAI1 employs both positive and 
negative regulation to repress the TTX-like transcription state in cultures with stable basal levels 
of activity (Fig. 3-3B-D). Of note, BIC-response genes, which show no dependence on RAI1, 
also showed RAI1-peak enrichment (Fig. 3-8C); therefore, RAI1 at these genes is dispensable 
for suppressing BIC-triggered transcription.  
 
RAI1 directly contributes to transcriptional response to TTX  
Finally, we inspected the 98 RAI1 peaks found in TTX-treated cultures, because we detected a 
compromised transcriptional response of Rai1-KD cells to TTX (Fig. 3-5C-E). Most of these 
peaks were common between the TTX and Veh conditions (promoter-occupied: 89% overlap, 
non-promoter-occupied: 77% overlap, Fig. 3-8H). We found a much greater proportion of non-
promoter peaks (60%) compared to the resting cells (22%) (Fig. 3-8I). Thus, RAI1 at non-
promoter regions preferentially persists when network activity decreases. The genes bound or 
nearest to these RAI1-TTX peaks showed incomplete induction and suppression upon TTX 
treatment of Rai1-KD culture (Fig. 3-7G) but not upon BIC treatment (Fig. 3-8J). These results 
suggest that RAI1 directly contributes to the transcriptional response (both negative and positive) 




Figure 3-8. Further RAI1 ChIP-seq analysis, related to Fig.3-7.  
(A) Number of reads of ChIP-seq samples mapped to mouse (mm9) or fly (dm6) genomes.  
(B) Western blot for RAI1 (N=3). Rat cortical neurons (DIV14) were treated with TTX (T), BIC (B) or vehicle (V) for the 
indicated times. The 270-kDa full-length RAI1 protein band intensity was visualized and quantified in the linear range using LI-
COR C-Digit and Image Studio software. No treatment reached p<0.05 (one-way ANOVA).  
(C) Enrichment of RAI1-peaks at the promoters of TTX up, TTX down, BIC up and BIC down genes. (Chi-square test, p=2.2e-16)  
(D) Gene ontology enrichment of RAI1-promoter-bound genes in baseline condition.  
(E) The majority of RAI1-promoter-bound genes in our study overlap peaks found in in vivo RAI1-ChIP-seq data 2 
(F) Top HOMER Known motifs enriched in RAI1 gene promoters (Veh).  
(G) RAI1-binding is enriched in RAI1-dependent genes.  
(H) The majority of peaks in the TTX condition are shared in the Veh condition.  
(I) The majority of peaks in the TTX condition are non-promoter peaks.  
(J) Genes bound by RAI1 in the TTX-treated condition do not show a correlation with incomplete BIC-response.   
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Loss of RAI1 prevents synaptic upscaling but not downscaling 
We next examined RAI1’s role in homeostatic synaptic scaling induced by chronic activity 
suppression (TTX, 24 hr) or chronic network hyperactivation (BIC, 24 hr). Consistent with the 
dysregulation of TTX-responsive genes by Rai1-KD after TTX treatment (Fig. 3-5 and Fig. 3-7), 
we found that loss of RAI1 significantly impaired the induction of homeostatic upscaling during 
activity suppression in a cell-autonomous manner. Following transfection of scrambled or Rai1-
targeted shRNAs (24 hr prior to TTX/BIC), we found that control neurons expressing the 
scrambled shRNA exhibited the normal increase in mEPSC amplitude 24 hr post-TTX (sh-Ctrl 
Veh vs TTX: n = 29-21, p < 0.0001, Fig. 6A-B) and the distribution of mEPSCs exhibited a clear 
and multiplicative rightward shift in cumulative frequency plots.  By contrast, mEPSCs from 
neurons expressing either of two distinct Rai1 shRNAs did not significantly increase following 
TTX exposure (Fig. 3-9A-C).  Importantly, expression of an RNAi-resistant RAI1 fully rescued 
TTX-induced upscaling (Fig. 3-9A-C).  Despite a clear role in homeostatic upscaling, Rai1-KD 
had no effect on the induction of homeostatic downscaling following network hyperactivation 
with BIC (Fig. 3-9D-F).  Both control neurons expressing scrambled shRNA and those neurons 
expressing Rai1-shRNA exhibited significantly decreased mEPSC amplitudes (sh-Ctrl Veh vs 
BIC: n = 26-17, p = 0.0026, sh-Rai1-#1 Veh vs. BIC: n = 21-8, p = 0.0003 and sh-Rai1-#2 Veh 
vs. BIC: n = 12-8, p < 0.0001, Fig. 3-9E), as well as a clear leftward multiplicative shift in 
mEPSC cumulative probability distributions (Fig. 3-9F).  These results demonstrate that RAI is 
essential for homeostatic upscaling during activity suppression, but is otherwise dispensable for 







Figure 3-10. RAI1’s role as a state-dependent transcriptional regulator of TTX-response genes. 
RAI1 alters synaptic efficacy through activity-dependent chromatin binding and plays essential roles in 
regulating TTX-response genes under baseline and activity-suppressed states. 
Figure 3-9. Rai1-KD impairs synaptic upscaling but not synaptic downscaling.  
(A) Representative mEPSC traces recorded from neurons transfected with either sh-Ctrl, sh-Rai1 or Rescue 
and treated with either vehicle or 1 µM TTX. Scale bar, 20 pA, 150 ms   
(B) mEPSC amplitude of sh-Ctrl, sh-Rai1 #1, sh-Rai1 #2 or Rescue and treated either with vehicle or TTX 
(sh-Ctrl Veh, TTX n = 29-21, sh-Rai1 #1 Veh, TTX n = 22-7, sh-Rai1 #2 Veh, TTX n = 9-8 and Rescue 
Veh, TTX n = 14-15).  
(C) Cumulative distribution of mEPSC amplitude for sh-Ctrl (left), Rai1-KD (sh-Rai1 #1 + #2, middle) and 
Rescue (right) comparing vehicle vs. TTX.  
(D) Representative mEPSC traces recorded from neurons transfected with either sh-Ctrl or sh-Rai1 and 
treated with either vehicle or 10 µM BIC. Scale bar, 20 pA, 150 ms.  
(E) mEPSC amplitude of sh-Ctrl, sh-Rai1 #1 and sh-Rai1 #2 treated either with vehicle or BIC (sh-Ctrl Veh, 
BIC n = 26-17, sh-Rai1 #1 Veh, BIC n = 21-8, sh-Rai1 #2 Veh, BIC n = 12-8).  
(F) Cumulative distribution of mEPSC amplitude of sh-Ctrl (left) and sh-Rai1 (sh-Rai1 #1 + #2) treated with 
vehicle (black) or BIC (blue). All bar graphs are represented as mean ± SEM, and unpaired Student’s t-tests 





Several lines of evidence support a model where RAI1 acts to constrain synaptic upscaling in 
networks with baseline levels of activity by preventing premature transcriptional responses 
normally driven by altered network activity (Fig. 3-10). First, RAI1 deficiency shifts gene 
expression towards TTX-associated transcriptional states (Fig. 3-3). Second, RAI1 occupies its 
target promoters strongly in the resting cells, and dissociates when network activity shifts (Fig. 
3-5). Third, Rai1-KD led to an increase in excitatory synaptic strength, reflected by enhanced 
mEPSC amplitudes and associated with an increase in network firing rate (Fig. 3-3). Our data 
further indicate the additional role of RAI1 in promoting synaptic upscaling when the network 
experiences prolonged activity depression (Fig. 3-9). This latter role of RAI1 again involves 
direct control of TTX-induced transcriptional responses (Fig. 3-5 and Fig. 3-7). The most 
remarkable aspect of these observations might be the predictive capability of Bru-seq results for 
RAI1’s roles in chromatin regulation and synaptic plasticity.  
 
It is noteworthy that all the four previously characterized chromatin regulators in synaptic 
scaling, i.e. TET3, EHMT1/2, L3MBTL1 were chosen for investigations, because network 
activity alters their expression or target histone modifications 21-23. We found no indication that 
neuronal activity influences RAI1 expression (Fig. 3-1A and 3-8B). These observations suggest 
that chromatin regulators linked to human cognitive disorders could participate in synaptic 
scaling and other forms of transcription-dependent plasticity, even when their expression remains 
stable during the process. The predominant chromatin occupancy by RAI1 during stable periods 
of network activity (Fig. 3-5) is unique among the scaling-associated chromatin factors, which 
all appear to be activated by network activity alterations. Post-translational modifications on 
RAI1 itself or chromatin are potential mechanisms for the RAI1 dissociation from chromatin. 
Thus, RAI1 offers a molecular mechanism that stabilizes network activity and future 
investigations may uncover a similar mode of action in other chromatin regulators associated 
with human cognitive deficits.  
 
How do RAI1’s roles in synaptic scaling relate to cognitive function?  Thorough characterization 
of cell-type specific Rai1-KO mice attributed their learning deficits to GABAergic interneurons 
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rather than glutamatergic excitatory neurons 2, although human SMS patients exhibit RAI1 
heterozygosity in all cells. Since we measured mEPSCs in the pyramidal cells that incorporated 
the sparsely transfected Rai1-shRNA plasmid, RAI1’s role in synaptic scaling is cell-
autonomous to excitatory neurons. The lack of learning deficits in forebrain-specific Rai1-KO 
(Emx1-Cre:  Rai1flox/flox) may suggest that impaired cognitive function is independent of RAI1’s 
role in synaptic scaling. Alternatively, unknown genes may compensate for synaptic scaling 
deficits caused by acute Rai1 depletion during development thus obscuring the contribution of 
RAI1 in excitatory neurons. Of note, a recent study reported reduced dendritic spine density in 
the prefrontal cortex of 4 week old Rai1-heterozygous mice 78, suggesting important effects of 
RAI1 deficiency in excitatory neurons that may relate to RAI1’s role in synaptic upscaling 
identified here. Identifying RAI1-target genes that mediate the synaptic phenotype will 
illuminate the molecular pathways underlying the cell autonomous roles of RAI1.   
 
A limitation of the Bru-seq approach is the lack of cell-type specificity. Recently, Zajaczkowski 
et al. reported nascent RNA-sequencing specifically in neurons 84. They used Synapsin I 
promoter-driven expression of uracil phosphoribosyltransferase (UPRT) to label RNAs of 
neurons. The UPRT system identified over 3,000 depolarization-regulated genes over the 3 hr 
KCl treatments, which likely detected both nascent transcripts and steady-state mRNAs. Cell-
type specificity of the UPRT system comes with the cost of introducing the UPRT transgene and 
additional experimental steps to label RNAs. Furthermore, single-cell RNA-seq of Rai1-KD 
neurons might illuminate cell-type-specific roles for RAI1. Single-cell RNA-seq, however, 
mostly characterizes poly(A)-selected steady-state mRNAs. Thus, it will be important to choose 
the most suitable experimental approach for RNA profiling depending on specific goals of the 
study.   
 
Our studies further identify a unique role for RAI1 in homeostatic synaptic plasticity, where 
during stable patterns of activity, it suppresses a transcriptional program engaged during 
neuronal inactivity. This work underlines the association between neuronal activity dependent 
transcription and the functional axis of experience dependent synaptic plasticity (Figure 1-1). 
However, RAI1 demonstrates a role for chromatin regulators in the maintenance of the baseline 
state of the activity-dependent transcriptome. L3MBTL and EHMT1/2, which perturb synaptic 
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up- and/or down-scaling, do not perturb baseline synaptic strength, suggesting that baseline state 
regulation is not a ubiquitous feature of chromatin regulators. It remains to be explored whether 
RAI1 is one of many nucleosome binding proteins that bind to chromatin and regulate activity-
dependent transcription predominately baseline conditions.  
Speculation on the RAI1 complex  
 
It is worth considering whether evidence of a RAI1 complex is consistent with our findings. 
Chromatin regulatory proteins, including H3K4me regulators, generally operate within stable 
multi-subunit complexes 85. Such a complex typically contains histone modifying enzymes, 
reader proteins, and protein scaffolds. Using a unique proteomics approach, Eberl et al. 
discovered that RAI1 is an integral component of a putative chromatin regulatory complex. The 
authors used a label-free proteomics approach to identify reader proteins that specifically 
recognize well-characterized histone methylations including histone H3K4me3 4. Brain, kidney, 
and liver tissue lysates taken from adult mice were filtered through columns containing 
unmethylated H3K4 or H3K4me3 peptides, and eluates were analyzed by tandem mass 
spectrometry. Consistent with a previous report 86, PHF21A was identified as a protein that binds 
to unmodified H3K4 and repelled by H3K4 methylation. In the H3K4me-repelled fraction, they 
identified a novel protein complex, which consists of iBRAF, Retinoic Acid Induced 1 (RAI1), 
Plant Homeodomain-containing Factor 14 (PHF14), and Transcription Factor 20/Stromelysin-1 
Platelet-derived growth factor-responsive element Binding Protein (TCF20/SPBP).  
 
Figure 3-11. Putative RAI1 complex. The RAI1 complex may consist of four non-enzymatic histone- and DNA-
binding proteins3,4. NBD=nucleosome binding domain. ePHD= extended plant homeodomain. CC: coiled coil. HMG= 




Unlike typical chromatin regulatory machineries, the RAI1 complex lacks histone-modifying 
enzymes. Notably, PHF14, RAI1, and its paralogue TCF20 (SPBP) carry putative methyl-histone 
recognition modules: PHDs and extended PHDs (ePHDs) (Figure 3-11) 87, suggesting reader 
function of the complex. The present work demonstrates that RAI1 can both activate and repress 
transcription depending on the target genes (Fig. 3-5). I speculate that RAI1 functions to recruit 
distinct histone modifying proteins in the baseline state to activate TTX-downregulated genes 
and to repress TTX-upregulated genes. Which protein? We previously reviewed the potential 
interaction of RAI1 and the histone methyltransferase MLL1/KDM2A across early 
neurodevelopment 3. RAI1 may interact with MLL1 in the context of synaptic plasticity, as both 
RAI1 and MLL1 are expressed in mature neurons. Alternatively, like RAI1, TET3 and 
EHMT1/2 have been demonstrated to have important roles in homeostatic upscaling 21,22. While 
TET3 positively regulates transcription by removing CpG methylation 88, EHMT1/2 generally 
acts as a transcriptional repressor by placing the repressive histone H3K9 methylation mark 89. 
Thus, the two facets of RAI1’s role in transcriptional dynamics could be through interactions 
with positive and negative transcriptional regulators, such as TET3 and EHMT1/2. An 
interaction with TET3 at baseline is a tempting explanation, as loss of TET3 in neurons appears 
to not only regulate TTX and BIC-responsive scaling, it also upregulates baseline synaptic 
strength, similar to RAI1 21. (It should be noted that the authors did not statistically test for this.) 
Therefore, in this model, RAI1 may recruit TET3 at baseline, then departs the chromatin in 
response to low or high activity, while other histone recognition complexes recruit TET3 to other 
loci important for the scaling process.  
 
Another aspect of the RAI1 complex to consider is the current evidence of its association with 
distinct histone modifications. The RAI1 complex binds to unmethylated H3K4, whereas 
H3K4me3 repels RAI1 4, which suggests that methyl-recognition may be correlated with the 
dynamics of RAI1 chromatin binding in response to activity. Previous studies have shown that 
H3K4me3 increases globally in response to picrotoxin, a GABA-A receptor antagonist which 
increases neural activity levels like BIC. Similarly, H3K4me3 trends towards a global increase in 
response to TTX 22. This is consistent with RAI1’s dramatic repellence from the chromatin under 
BIC, and somewhat less strong repellence after TTX. Therefore, RAI1 may serve to recruit 
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H3K4me3 methyltransferases, thus concurrently displacing itself, in a read-recruit-leave 
mechanism.  
 
However, RAI1 also has been shown to be associated with H2A.Z, which is found to be enriched 
at both active and repressed gene promoters 90,91. In the cerebellar cortex, H2A.Z has been shown 
to be integrated, via the NuRD complex, into the promoters of activity-response genes after 
cessation of neural stimulation 92.  Upon returning to normal baseline levels of activity, H2A.Z is 
incorporated into activity-dependent promoters, and it appears to prevent too dramatic a 
reduction in expression. That is, loss of H2A.Z reduces post-stimulation expression of activity-
dependent genes. This suggests H2A.Z may help to regulate baseline transcription set points. As 
a mediator of baseline transcription of activity-dependent genes and a potential binder of H2A.Z, 
RAI1 may take part in this mechanism of set point establishment through H2A.Z binding.  This 
could be analyzed by examining RAI1-chromatin interactions before and after baseline states 
have been achieved during synaptic plasticity.   
In sum, future analyses of RAI1’s molecular interactions, through biochemical binding assays 
and mass spectrometry, will help to determine the mechanisms by which RAI1 regulates baseline 
transcription of activity-dependent genes. 
Potential Lessons 
Often, initial examination of a protein of interest’s function involves RNA-sequencing of 
control/WT and KD/KO cells, with the selection of differentially expressed genes as the next 
step to highlight pathways of interest. However, this may obscure trends in transcription that are 
unknowable unless directly compared with other states. For example, RAI1 dependent genes at 
baseline showed mild fold changes, and were composed of numerous TTX and BIC responsive 
genes, with enrichment in broad gene ontologies that did not indicate a likely mechanistic 
pathway. However, by comparing Rai1-KD genes with gene sets known to be associated with 
neuronal inactivity and hyperactivity, a clear hypothesis could be formed: loss of RAI1 pushed 
cellular state towards an inactivity-like transcriptome. This potentiated further analysis of 
downstream phenotypes. In this sense,  RNA-sequencing studies can be designed to include 
“reference states” as comparison; for example, the study of loss of a neurodevelopmental gene at 
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E16 can be compared with the transcriptome of E12 vs E18 brains to search whether the gene 
aberrantly delays or accelerates the developmental transcriptome. Alternatively, the 
transcriptome resulting from loss of a gene of interest can be compared to the transcriptomes 
resulting from loss of genes with other known phenotypes. This approach would be useful in the 
case of a confident hypothesis or pursuit of a specific mechanism of interest. Also, since gene 
expression may be disrupted in only a subset of cells, relying on trends instead of significant 
genes may allow sensitivity to cell-subtypes specific changes without relying on more 
technically challenging techniques such as single-cell RNA sequencing or cell-type specific 
nuclei isolation. 
Similarly, sole reliance on significant gene expression changes can lead to missed mechanisms, 
especially when examining chromatin regulators, which regulate high numbers of genes, or 
profiling dynamic gene expression at a single time point across development or after a stimulus, 
since the time point chosen may not represent the most robust differential expression. Therefore, 
examining sub-significant gene expression changes allows further gene-network-level analysis. 
For example, we found that Rai1-KD mildly upregulated Per2 by 25%, which is undetectable by 
typical qPCR and was not be detectable at the protein level through Western blot analysis. 
However, examination of sub-significant trends revealed that many circadian genes were altered 






Potential Roles of RAI1 in Circadian Rhythms 
Introduction 
 
Circadian rhythms represent an internal clock for animals to adapt their physiology to the day 
and night cycle. Recent transcriptome studies using all major organs in mice revealed that 
approximately 45% of protein-coding genes show circadian expression in at least one organ, and 
that 10% of genes oscillate in a given cell type 93,94. This suggests pervasive yet cell-type and 
tissue-specific variations in circadian gene regulations. The core of circadian oscillatory gene 
expression is a transcriptional negative-feedback mechanism, whereby a heterodimer of the 
transcription factors CLOCK and BMAL activates transcription of their negative regulators 
PER1/2 and CRY1/2 in a 24 hour cycle 95.   
 
Circadian gene regulation is associated with periodic relaxing and compacting of chromatin 
structure at gene promoters 96. Several chromatin regulators, including CLOCK itself as a histone 
acetyltransferase, have been shown to contribute to the circadian transcriptional program 97. In 
reminiscence of activity-dependent gene expression, chromatin regulators that are associated 
with neurodevelopmental disorders also appear to be critical for circadian gene expression. 
These include RAI1, the histone methyltransferase MLL, the histone demethylases LSD1 and 
KDM5A 95,96,98-100. Therefore, sleep disturbance observed in the neurodevelopmental conditions 
associated with these genes may be a consequence of impaired circadian transcription.  
 
In the case of RAI1, clinical analyses first implicated its role in circadian rhythms. Every 
reported individual with SMS experienced subjective sleep disturbances such as daytime 
sleepiness and frequent nighttime awakenings 101. The production of melatonin appears to be a 
primary factor in the observed sleep abnormalities of SMS. Melatonin is a key hormone secreted
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by the pineal gland during the night, thereby synchronizing the circadian clock throughout the 
body 102. While most individuals with SMS display an inverted secretion pattern of melatonin, in 
rare cases, a normal melatonin secretion pattern accompanies sleep disturbance 103,104. This raises 
the possibility that melatonin-independent mechanisms underlie the sleep abnormalities in SMS. 
Indeed, heterozygous Rai1 ablation in C57/BL6 mice, which are known to lack melatonin 
secretion, is sufficient to impair circadian behaviors74. 
 
Mechanistic studies further support the role of RAI1 in intrinsic circadian regulation, 
independent of melatonin-mediated endocrine system. RAI1 knockdown in cultured cell lines led 
to reduced and shortened oscillation of CLOCK target genes 105. The reduced expression of 
circadian genes was also observed in fibroblasts derived from individuals with SMS 105. 
Furthermore, RAI1 was found to directly occupy an intron of the CLOCK gene and promote its 
transcription 105. However, a comprehensive understanding of RAI1’s role regulating key 
circadian genes and neuronal function remain undiscovered.  
Loss of RAI1 alters genes associated with CLOCK and PER2 Regulation 
 
Intriguingly, our dataset supports the hypothesis that RAI1 interacts with the circadian 
transcriptome. In the Bru-seq dataset, the top gene upregulated by Rai1-KD is Per2, which 
encodes a key circadian regulator. PER2 antagonizes the function of CLOCK, a histone 
acetyltransferase responsible for activating circadian genes106. Electrophysiological recordings 
from cortical slices derived from Clock-mutant mice display increased synaptic strength, 
suggesting CLOCK activity represses synaptic strengthening 107. As PER2 antagonizes CLOCK, 
I hypothesized that PER2 may function to induce synaptic strengthening. Bru-seq revealed that 
in TTX-treated cultures, Rai1-KD decreases Per2 expression (Fig.4-1). At baseline activity, 
Rai1-KD increases Per2 transcription. At high activity, Rai1-KD does not affect Per2 
transcription. I hypothesized that RAI1 switches in an activity-dependent manner from an 






If RAI1 dysregulates Per2 transcription, does it affect PER2 protein levels? While tested 
antibodies appeared non-specific (data not shown), it would be predicted that PER2-target genes 
would be disrupted by Rai1-KD. Therefore, I took a list of genes upregulated be Per2-KD in 
human embryonic stem cells 6. These are putative PER2-upregulated genes. If my model were 
correct, Per2-upregualted genes would be expected to be downregulated by Rai1-KD at baseline. 
When plotting the effect of Rai1-KD on these genes, I found indeed that these genes 
predominately trended towards downregulation, in support of the model (Figure 4-3). 
Since another CLOCK-target gene, Cry1, was dysregulated by Rai1-KD at baseline, I searched 
to see whether CLOCK-target genes were enriched in Rai1-KD genes. Using the 2016 ChIP-X 
Figure 4-1. RAI1-dependent Per2 transcription in 
baseline and inactivity state.  
(A) UCSC Browser tracks showing activity-dependent 
effect of Rai1-KD on Per2 expression. Per2 expression 
is decreased by Rai1-KD in low-activity cultures, (23%, 
FDR: 0.15) and increased by Rai1-KD at baseline 
activity 37%, FDR: 0.006). Rai1-KD does not perturb 
Per2 expression under conditions of high activity (FDR: 
0.6)  
(B) RAI1 acts as an activator and repressor of effector 
genes, including Per2, under conditions of low and 
baseline activity, respectively. These effector genes lead 
to synaptic strengthening through unknown mechanisms 
(green arrow). We propose PER2 leads to synaptic 
strengthening by blocking the function of CLOCK, a 
repressor of synaptic strength. High activity inactivates 





Enrichment Analysis software, I found that RAI1-dependent baseline genes are significantly 
enriched for CLOCK binding sites 108. Although this experiment was performed in human 293T 
cells, this provides evidence that RAI1 may more broadly regulate CLOCK-target genes, either 
through suppression of Per2 transcription or through direct recruitment of CLOCK. 
  
Discussion 
Our work and previous studies have implicated RAI1 in circadian gene regulation, activity-
dependent gene regulation, and synaptic scaling. Further experiments are required to establish 
how RAI1’s roles in these processes interact. RAI1 may play independent roles in each of these 
processes, or one or more pairs of processes may be functionally linked. Circadian clocks in 
cultured non-neuronal cells are synchronized by serum shock or chemical agents such as 
dexamethasone, hydrogen peroxide, or forskolin 109. These treatments intersect with pathways 
important for neuronal activity, e.g. forskolin phosphorylates CREB. The intersection between 
metabolic and neuronal activity pathways suggests that treatment of TTX or BIC may also serve 
to synchronize circadian clocks in neurons, though this has not yet been published.  
Since the RAI1 chromatin binding phenotype is strong, it would be interesting to test if RAI1 
chromatin binding is altered across circadian time and/or sleep/wake cycles in vivo. Since 
Figure 4-2. RAI1-target genes are regulated by PER2 and CLOCK 
(A) ChEA 2016, Enricher Software outputs a significant enrichment for CLOCK binding motifs based on 
Human 293T ChIP-seq experiment.1  
 
(B) Genes upregulated by Per2-KD in human embryonic stem cells (hESCs)6 are downregulated by Rai1-





daytime/wake is associated with higher inputs from environment, it may be analogous to BIC 
treatment; in this sense, RAI1 may be dispensable for this time of the circadian clock. However, 
nighttime/sleep may be analogous to TTX treatment. Although RAI1 departs the chromatin at 4 
hours post TTX treatment, RAI1 appears essential to achieve the full amplitude of TTX-response 
genes, suggesting RAI1 may be necessary for this state or this time of the circadian clock. 
Therefore, loss of RAI1 may interfere with the circadian nighttime state. In cultured neurons, 
loss of RAI1 led to net increase in neuronal firing. If RAI1 has cyclic binding to the chromatin 
that peaks at the transition between day and night (CT12) but diminishes by CT16 (4 hours post 
TTX) and remains low throughout CT4 (4 hours post BIC) , this may coincide with our data. 
This leads to the hypothesis that loss of RAI1 would cause aberrant synaptic strengthening and 
increased neuronal firing at the nighttime state.  
By what mechanism might RAI1 exert circadian influence on the chromatin? Many histone 
marks, including H3K4me3, shows circadian cycling 110. We have previously identified a 
putative interaction between RAI1 and known H3K4me regulators LSD1 and MLL 3. Briefly, 
RAI1 is part of a complex that appears to counteract LSD1/REST’s inhibition of neuronal genes 
across neurodevelopment by recruiting MLL. This potential interaction may be at play in the 
circadian clock. LSD1 appears to be directly involved in the core CLOCK-BMAL machinery of 
circadian transcription. LSD1 can be phosphorylated by PKCα at a specific serine residue (S112) 
in a circadian manner  100 (Figure 4C). The phosphorylation of LSD1-S112 directly recruits 
and/or stabilizes CLOCK-BMAL on chromatin, which in turn activates CLOCK-target genes. 
Replacement of wildtype LSD1 with the phosphorylation-deficient p.Ser112Ala mutant in mice 
resulted in impaired circadian rhythmicity at molecular and behavioral levels 100. The circadian 
role of LSD1 is independent of its demethylase activity 100,111.  
 
In contrast to the catalysis-independent roles of the demethylases, MLL1 appears to govern 
circadian oscillation by trimethylating H3K4 99. MLL1 was shown to be recruited to promoters 
via the CLOCK-BMAL complex, in turn activating circadian gene expression in mouse 
embryonic fibroblasts. In principle, rhythmic expression of genes requires gene activation 
followed by transcriptional repression. A more recent study showed that MLL1 can be acetylated 
at several lysine residues, and that the acetylation can be removed by the deacetylase SIRT1 in a 
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circadian manner 112 (Figure 4D). SIRT1-mediated deacetylation of MLL1 from residues K1130 
and K1133 appears to diminish the H3K4 methyltransferase activity of MLL1. MLL1 regulates 
thousands of genes with broad functions, thus this work raised an exciting possibility that MLL1 
generates circadian oscillation of the H3K4me landscape genome-wide, thereby controlling 
broader physiology in a circadian manner. RAI1’s involvement in circadian rhythms may be in 
part related to its recruitment or stabilization of MLL1 on the chromatin. However, alternative 
interactions may be possible.  
The drastic symptom of inverted sleep patterns in individuals with Smith-Magenis syndrome 
(SMS) makes this a particularly interesting molecular axis to examine with relevant applications 
in therapeutics. Furthermore, as the role of synaptic scaling in sleep begins to be more 
thoroughly tested, SMS models may prove valuable given the known human symptoms and the 




Neuronal Activity-Dependent Promoter Selection 
Introduction 
Neuronal activity does not only alter gene expression levels, but alters transcriptional processing 
and post-transcriptional modifications. For example, genome wide-analyses have shown activity-
dependent alternative splicing 113, including use of microexons 114, activity-dependent AU 
editing 115-118 and activity-dependent enhancer usage 119,120.  Therefore, observing activity-
dependent transcriptional mechanisms beyond up- and down-regulation of genes may give 
insight into how neurons alter the transcriptome and proteome.  
One mechanism that has been relatively unexplored is the use of alternative promoters or 
transcription start sites (TSS) in response to neuronal activity. Activity-dependent promoter/TSS 
usage has been observed in specific neuronal genes. For example, the gene BDNF contains four 
promoters, two of which are known to be activity-dependent 36,121. Interestingly, the protein 
products from each of these four promoters are identical 122,123. It has been suggested that the 
untranslated region results in differential localization of mRNA in the neuron 124,125. However, 
estimates of the number of mammalian genes with multiple transcription start sites have been as 
high as 56% 126-128. Many propose that distinct transcription start sites are essential for 
development and/or cell-type specific expression. Indeed, whole-genome analyses of promoter 
usage suggest that in the cerebellum, alternative promoters are used differentially across 
developmental time129.  
The limited knowledge about activity-dependent TSS is in part due to the specific sequencing 
methods required for TSS profiling. Standard RNA-sequencing often depletes 5’ ends of genes, 
preventing robust detection of changes in TSS 130. Often, cap-analysis of gene expression 
(CAGE) coupled with sequencing, or transcription-start-site-sequencing (TSS-seq) have been 
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used to analyze the usage of transcription start sites. These techniques are effective, but they do 
not profile whole gene expression, and have not yet been used in combination with nuclear or 
nascent RNA-sequencing in order to analyze dynamic activity-dependent gene expression. 
However, our use of Bru-seq by chance potentiated the discovery of activity-dependent promoter 
usage. The Bru-seq method produced abundant intronic reads which allowed the first intron to 
prove as a much more robust signal of TSS usage. For RNA-sequencing analyses to corroborate 
our studies, we used the DLAF method, developed in the Iwase lab to enrich for 5’ reads that 
allowed analysis of switches in promoter usage while examining mRNAs 131. I developed the 
DLAF protocol for low-input RNA allowing sequencing of TSS usage from RNA derived from 
in vivo experiments to find whole-tissue and excitatory neuron-specific examples of activity-
dependent promoter usage. Promoter usage predominately appears to switch protein level 
changes, including the presence of N-terminal localization signals. We demonstrate that the 
switch in localization signal of a phosphodiesterase PDE2A is essential for the localization of 
PDE2A to the mitochondria and for electrophysiological properties of neurons. In sum, the role 
of differentially regulated activity-dependent promoters may be important for synaptic plasticity 
more broadly.  
A minority of expressed genes contain multiple active promoters in neuronal cultures 
In our Bru-seq study (Fig 2-1), the top gene upregulated by TTX (Prkag2) showed an interesting 
pattern of activity-dependent expression (Fig. 5-1A). The upregulation appeared due to the 
activation of an upstream promoter in response to TTX treatment. ChIP-seq for H3K4me3 and 
H3K4me1 from mouse cortical neuronal cultures supported that this was an active neuronal 
promoter 132. To determine if other genes displayed this phenomenon, I developed a custom 
pipeline to detect more instances of alternative promoter usage in neuronal cultures (Fig. 5-1C). I 
found that of the 12,260 genes expressed over a threshold in neuronal cultures, 909 (7.4%) show 
multiple active promoters. Activity-dependent genes are significantly enriched for genes with 
multiple active promoters, 9-13% compared to 4% of non-responsive genes, when examined by a 
Chi-square test (Fig 5-1C). Genes with multiple promoters showed gene ontology enrichment for 
neuron development and nervous system development, suggesting neuron-associated genes are 
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Figure 5-1. Multiple promoter genes expressed in mixed in vitro neuronal cultures.  
(A) Prkag2, the top gene upregulated by TTX, shows upregulation of the upstream promoter.  
(B) Pipeline to discover genes with multiple active promoters yielded 909 genes (7% of expressed genes).  
(C) Genes differentially expressed between TTX and BIC treatment conditions are enriched in multi-
promoter genes.  
(D) Multi-promoter genes are enriched for neuronal gene ontologies compared to all expressed genes. 
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A subset of multi-promoter genes show differential usage of each promoter in response to 
activity shifts 
To assess whether multi-promoter genes regulated promoter usage distinctly as in the case of 
Prkag2, I designed a pipeline to assess the ratio of reads in each TSS region compared to a 
downstream reference region (Fig. 5-2A). I used a linear model with a dummy variable for the 
treatment of Veh vs BIC, Veh vs TTX, or TTX vs BIC to detect the genes with activity-
dependent alterative TSS usage. Using a false discovery rate of 0.1 and a minimum absolute 
correlation of 0.1, I found 102/909 genes (11%) of all genes with multiple promoters show 
differential usage above these cutoffs (Fig. 5-2A). Top most significant genes are shown in Fig. 
5-2B and included Prkag2 and the synaptic genes Nrxn2 and Dlgap1. To examine whether multi-
promoter genes with activity-dependent differential usage of promoters (ADDUP) are enriched 
in activity-dependent genes, we calculated the proportion of activity dependent genes by 
examining significantly regulated genes between the TTX and Vehicle condition, the BIC and 
Vehicle condition, and the TTX and BIC condition. The genes upregulated by BIC are 
significantly enriched for ADDUP genes, suggesting whole-gene induction of transcription by 
activity is correlated with differential usage. The ADDUP genes, compared to all multi-promoter 
genes are enriched in gene ontology terms for calcium-mediated signaling, amine transport, 
voltage-gated calcium channel complex, and cyclic nucleotide binding, suggesting critical 





Figure 5-2.  Activity-dependent differential usage of promoters (ADDUP) occurs in a minority of multi-promoter 
genes.  
(A) Pipeline revealed 102/909 (11%) of genes show differential usage of promoters in response to neural activity shifts.  
(B) Multi-promoter genes that achieve an FDR <0.1 and a coefficient greater than the elbow point when comparing TTX 
v BIC read ratios.  
(C) Genes upregulated by BIC are enriched for differential usage of promoters.  





In vivo stimulation of mouse visual cortex yields ADDUP genes 
To examine whether alternative promoter usage occurs in vivo in response to physiological 
stimuli, we used a light-stimulation paradigm in adult mice47. Light stimulation is not only 
successful at inducing changes in neuronal activity in a reasonable proportion of neurons , but it 
has been associated with synaptic scaling133,134. We exposed a cohort of 6 adult female mice (8 
week) to 72 hr darkness, then re-exposed 3 mice to bright light for 4 hr (Fig 5-3A). We then 
sacrificed the mice, dissected the V1 visual cortices and the S1 somatosensory cortices. We 
utilized a modified form of direct ligation of adaptors to the first-strand cDNA (DLAF) method 
to enrich for 5’ end of genes 130, and performed deep sequencing. We used the identical pipeline 
to analyze activity-dependent promoter usage in vivo and found 26 genes with ADDUP (Fig. 5-
3B). 11/26 genes (42%) were also found to be significant in the in vitro experiment (Fig 5-3B, 
inset Venn). However, there was a significant positive correlation between the linear model 
coefficients of in vitro and in vivo data, between all potential ADDUP genes (Fig 5-4C). The in 
vivo ADDUP genes were enriched for calcium channel gene ontologies, similar to the in vitro 







Cell-type specificity of alternative promoter usage 
To ascertain whether distinct promoters were induced differentially through cell-type specific 
regulation and whether transcripts were stably associated with ribosomes to be translated, we 
crossed Ribotag mice 135 with Neurod6-Cre mice to express an HA-tagged ribosomal subunit 
Rpl22 exclusively in excitatory neurons 136,137. We then repeated the experiment, this time 
immunoprecipitating excitatory neuron-specific ribosome-associated RNA  (Fig. 5-5A). Visual 
cortex showed a robust response in activity-dependent gene expression, while somatosensory 
cortex showed only one gene differentially regulated, validating the region-specific activation of 
neurons (Fig. 5-5B.) Analysis of whole-gene expression showed strong depletion of non-
excitatory neuronal genes, demonstrating the efficacy of Ribotag immunoprecipitation (Fig 5-
5C).  
After running the identical pipeline to capture ADDUP, we found no genes passed the threshold 
of significance after multiple comparisons corrections. However, once we relaxed the threshold 
to an uncorrected p-value <0.1, we found 23 genes that showed ADDUP , including the Rac 
GTPase-activator Elmo1, the nuclear-receptor binding protein Lrif1, and the phosphodiesterase 
Pde10a, which were found in the other datasets. These genes were enriched for metabolic 
process and stimulus response gene ontologies.  
Figure 5-3. In vivo brain tissue reveals differential promoter usage in response to physiological neural stimulation.  
(A) Experimental paradigm. Adult mice were placed into darkness for 72 hr, then either exposed to light or retained in 
darkness an additional 5 hours. Mice were sacrificed, and the visual cortices (and somatosensory cortices as control) were 
dissected and prepared for DLAF-mRNA sequencing.  
(B) Utilizing the pipeline in Figure 5-2, 26 genes were discovered to show differential promoter usage in multi-promoter 
genes in the light-induced condition. Eleven Genes overlapped with those found in in vitro Bru-seq experiment.  
(C) There is a significant correlation between coefficients of genes found in in vitro and in vivo datasets.  








 Protein sequence is altered by promoter usage 
Since alternative promoter selection can affect transcription and translation on multiple levels, 
we first examined whether alternative promoter selection altered the predicted peptide sequence 
of the encoded protein. In 88% of genes, protein coding sequence was altered by promoter 
selection (Fig 5-5A, top Venn). Many genes showed loss of annotated domains (Fig 5-5B), 
indicating altered function. However, a great many genes showed shorter or unannotated changes 
in peptide. Since a majority of genes are membrane-bound synaptic proteins, we examined 
whether signal peptide presence was altered in the list of genes with predicted protein-level 
changes due to promoter use. N-terminal signal peptides are short (~15 aa long) sequences which 
target a newly synthesized protein to the lumen of the endoplasmic reticulum. N-terminal 
peptides also are known to target proteins to the mitochondria. We used TargetP 5 to search for 
differential presence of signal peptides and mitochondrial localization signals in the N-terminal 
region of the protein isoforms found in Bru-seq, RNA-seq, and Ribotag-RNA-seq.  9% of protein 
level changes resulted in a predicted change to localization signal, either a signal peptide or a 
mitochondrial localization signal (Fig 5-5A, bottom Venn). One of these predicted changes 
included the phosphodiesterase PDE2A, a cyclic GMP and cyclic AMP cleavage protein found 
in neurons 138. Interestingly, Pde2a is one of the few ADDUP genes that respond to both TTX 
and BIC by preferentially activating the same promoter (Fig. 5-5C). The long isoform is 
relatively upregulated in the TTX and BIC conditions, while the shorter, mitochondrial 
localization signal containing isoform is relatively upregulated in the baseline condition. To 
assess whether these protein isoforms localized to the predicted location in our cultures, we 
Figure 5-4. Excitatory-cell specific, ribosome-associated mRNA transcripts reveal alternative promoter 
usage in vivo.  
(A) Ribotag mice were crossed with Neurod6-Cre mice and submitted to same activation of visual cortex. After 
dissection of cortices, ribosomes were immunoprecipitated and associated RNAs prepared with DLAF-mRNA-seq.  
(B) Whole-gene analysis reveals induction of activity-dependent genes exclusively in visual cortex.  
(C) Whole-gene validation of Ribotag immunoprecipitation from excitatory neurons.  
(D) Genes above the previous cutoff for coefficient and passing a relaxed cutoff of unadjusted p<0.1.  




overexpressed V5-tagged exogenous PDE2A isoforms in neurons and imaged their co-
localization with mitochondrial marker TOMM20 (Fig. 5-5C). We found indeed that the short 






Figure 5-5. Activity-dependent differential usage of promoters yields predicted protein N-terminal changes. A. 88% of ADDUP 
genes show a predicated N-terminal isoform change, while 9% show potential differential presence of N-terminal localization signal, as 
predicted by TargetP software5. B. Genes overrepresented in gene ontologies include synaptic genes and phosphodiesterases. C. 
Phosphodiesterase PDE2A shows altered ratio of usage in response to activity, with differential preference for the long Pde2a isoform 
after both BIC and TTX treatment. The short isoform contains a mitochondrial localization signal, and is preferentially used in baseline 
state. Exogenous expression of the long and short PDE2A isoforms in mouse neurons demonstrates the preferred mitochondrial 




Promoter-dependent subcellular localization drives synaptic changes in PDE2A 
Very few (9%) ADDUP gene promoter-dependent protein products show a change in the 
predicted signal peptide or mitochondrial peptide-targeting sequences (Figure 5-5A), suggesting 
promoter usage may not be solely to alter signal peptide sequences. However, previous literature 
demonstrates that the N-terminus can be a site of post-translational modifications that direct 
protein isoforms to distinct subcellular locations even without a signal peptide. For example, 
glutamate-interacting protein1 (GRIP1), which was found in our in vitro and in vivo dataset to 
display ADDUP,  has two promoters that result in the production of two proteins distinct only by 
19 N-terminal residues. One of these residues is a site of palmitoylation 139. This post-
translational modification targets one isoform of GRIP1 to the synapse 140. Thus, it appears 
promoter usage can direct protein localization even in the absence of a change in signal peptide. 
Overexpression of differential promoter isoforms of PDE2A alters electrophysiology 
Lastly, we wanted to determine experimentally the importance of the promoter switch to function 
of neurons. We therefore overexpressed the two isoforms of PDE2A, the long cytoplasmic form 
(Cyto-Pde2a) or the short mitochondrial-targeted form (Mito-Pde2a). We found that there was a 
significant difference in mEPSC amplitude between the Cyto-Pde2a and the Mito-Pde2a (Fig. 5-
6A). Cumulative probability plot showed a significant difference between control-transfected 
neurons and both isoforms. However, the Mito-Pde2a is closer to the baseline level cumulative 
probability, which is consistent with its predominate expression at baseline. However, the Mito-
Pde2a shows a striking increase in mEPSC frequency (Fig 5-6C), suggesting it may mediate 
synaptic regulation through multiple mechanisms, and that its concentration at baseline levels is 







Figure 5-6. Exogenous expression of promoter-dependent isoforms of ADDUP gene Pde2a alters mEPSC 
amplitude and frequency  
(A) Mito-PDE2A expression leads to a reduced mEPSC amplitude compared to the cyto-PDE2A isoform.  
(B) Cumulative probability of mESPC amplitude reveals significant shift of the cytoplasmic isoform towards 
higher amplitude.  




Our data show that ~7% of the brain’s transcriptome arises from multi-promoter genes, and that 
these multi-promoter genes are enriched in the activity-dependent gene set. Around 10% of these 
MGP display activity-dependent differential usage of promoters (ADDUP) at the timepoints 
tested. In the in vivo whole tissue and Ribotag data, both gene expression and ADDUP appeared 
more highly variable. However, there were similar examples in ADDUP in vivo, and exclusively 
in excitatory neurons. Experiments using more biological replicates in vivo, using nuclear RNA-
sequencing (e.g. conditional SUN1-expressing mice141,142) crossed with other cell-type specific 
promoters (e.g. from excitatory neuronal subtypes or layer 4 cells) may more robustly reveal 
ADDUP. As evidenced by our data analysis, ADDUP appears to be a method of increasing the 
cellular proteome. While many genes’ promoter-specific isoforms possess distinct functional 
domains, many show unannotated polypeptide changes. These N-terminal sites are therefore of 
interest to determine their role in protein function, localization, interaction, and degradation.  
 
Comparing multi-promoter genes with gene list of autism-associated genes from SFARI 
demonstrated a significant enrichment of autism spectrum genes compared to all expressed genes 
(18% vs 7%, Chi-square test, p=2.2x10-16 143. However, ADDUP genes were not enriched for 
autism spectrum genes compared to all multi-promoter genes (22% vs 18%, Chi-square test, 
p=0.2). This suggests that multi-promoter genes are associated with autism spectrum genes. 
Although promoter usage itself may or may not underlie these genes association with autism, 
understanding promoter usage in autism-associated genes is important, as promoter usage of 
these genes may be a target for therapeutics. While many of the multi-promoter genes found 
display homologous H3K4me3 peaks in human brain tissue, the ADDUP of the genes we found 
may be mouse-specific. Therefore, pluripotent-cell derived human neurons should be analyzed 
for ADDUP to determine functional conservation across species. 
The distinction between ADDUP and shifts in stable, translated mRNA remains to be 
determined. Because alternative promoters allow for distinct 5’ leader regions to be transcribed, 
miRNA silencing or translation initiation regulation mechanisms may be at work to either 
normalize or enhance the distinct production. While many experimental variables may cause the 
difference in ADDUP gene lists between Bru-seq and Ribotag experiments, alternative 5’ leader 
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processing may be behind the genes labeled ADDUP in our Ribotag experiment but not found to 
show ADDUP in Bru-seq.  
In sum, these activity-dependent promoters may be a key to mechanisms of plasticity and should 
be taken into account when designing qPCR primers, RNA-seq experiments, and antibody-probe 
design. The roles of non-protein level effects of promoter usage have yet to be explored as well, 
as 5’ UTR regulation is essential to RNA translation and neuronal function. Additionally, the 
transcription termination sites of these promoters, and alternative splicing, should be more 
deeply examined, as promoter usage may directly affect these processes as well.  
 
Broader perspectives 
Multi-promoter genes, whether their promoters are coordinately or differentially regulated, have 
broad potential for cellular regulation. The appearance of secondary promoters in these genes 
evolved to simultaneously express two forms of the protein: e.g. to produce a dominant-negative 
isoform to counterbalance the original isoform under all cellular conditions, or to produce 
isoforms targeted to distinct locations or binding partners. This was the case in the study on 
light-induced promoter usage in plants, where 78% of genes with alternative promoters encoded 
distinct protein isoforms, and 25% of these were predicted to alter subcellular localizations 144.  
However, since many multi-promoter genes contain very distal promoters, the energy and time 
required to transcribe the isoforms may be very distinct between promoters. This may itself 
function to direct differential time expression of isoforms, which could affect mRNA or protein 
product regulation 145, or to conserve ATP usage for purposes of cellular homeostasis.  
How would differential usage evolve? It may be that ADDUP are more likely to evolve when 
established multiple promoters were spaced distantly enough that transcriptional and chromatin-
level regulation could differentially regulate the two promoters. Indeed, the distance between 
promoters in ADDUP genes are significantly longer than the promoters in non-ADDUP multi-
promoter genes.  However, enough ADDUP genes are shorter than other multi-promoter genes, 
suggesting promoters that do not show differential usage upon neuronal activity shifts have the 




As evidenced by our data analysis, ADDUP appears to be a method of increasing the cellular 
proteome. However, we have not definitively demonstrated that ADDUP occurs intracellularly. 
Therefore, it could also be a way of diversifying cell types within the brain. For example, a 
subset of excitatory neurons receiving light stimulation in the visual cortex may respond by 
initiating transcription from an alternative promoter that acts to produce a protein isoform that 
enhances synaptic responses to the stimuli. This may be a mechanism through which distinct 
neuronal circuits can respond differently to sensory stimuli. To address this question, single-cell 
analysis of ADDUP genes will likely require techniques such as in situ hybridization and 
imaging. Single-cell sequencing methods are not currently adapted to the read coverage required 
to analyze promoter usage, though this is advancing with such protocols as RamDA-seq146. 
In addition to the effect of ADDUP on protein isoform expression, evidence shows that 
transcription start site usage can be correlated with alternative exon usage through exon-
mediated activation of transcription starts (EMATS). Proximal alternative exons may upregulate 
the use of weak alternative promoters through splicing-factor-mediated recruitment or 
stabilization of transcriptional machinery 147. Genes with such internal exons are enriched in 
brain development, neuron projection, and synapse organization. This phenomenon occurs 
mostly when the induced transcription start site is within 2 kb of the included exon. It is possible 
that neuronal activity activates downstream exon usage, which in turn activates a weak intragenic 
promoter.   
Many of our ADDUP genes occur in genes with long first exons (e.g. greater than 30 kb in 
length, data not shown). Genes with long first exons have been identified to exhibit recursive 
splicing, in which stepwise splicing events occur across the intron 148. These splicing factors may 
in turn take part in the activation, maintenance, or repression of promoter usage in these genes. 
Alternatively, ADDUP and recursive splicing could have co-evolved with first intron 
lengthening without having causal interaction with one another mechanistically.  
In contrast, there is evidence from plant studies that upstream promoter usage can inhibit 
downstream promoter usage 149. It was found that this was dependent on the FACT chromatin 
complex. The FACT complex is conserved in mammals and Supt16 and Ssrp1 are expressed 
ubiquitously in the brain 47. Furthermore, SUPT16 mutations have been associated with a 
neurodevelopmental disorder 150. Whether or not FACT chromatin complexes are functioning in 
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the brain similar to their function in plants remains an open question. Furthermore, how this 
phenomenon and the EMATS mechanism interact is relevant to understanding the multiple 
mechanisms at play in ADDUP.  
Despite the potential importance of ADDUP, our data demonstrate that the majority of these 
promoters are used coordinately at this stage of activity-dependent transcription in vitro, and 
with greater variability in vivo. It is likely that ADDUP genes found to robustly switch in our 
datasets (e.g. Elmo1) occurs more uniformly across many cells compared to less robust ADDUP 
genes which may switch promoter usage only in a distinct cell subtype. Alternatively, we may 
find that ADDUP occurs stochastically across cell types as a side effect of other cellular states. 
Examining ADDUP across cell types may pave the way towards understanding more broadly 
how common ADDUP is intracellularly versus across a population of cells.  
Remaining questions include the mechanism of switching these promoters. It is likely that these 
genes evolved to have stimulus-response promoters in a manner similar to the evolution of 
single-promoter genes. Therefore, it is not surprising to find known activity-dependent TF motifs 
enriched in ADDUP promoters. However, epigenetic and chromosome conformation may also 
control these promoters. The evolution of these promoters suggests these may play important 
roles in stimulus-dependent processes in other cell types, specifically other calcium-signaling 
cell types such as cardiomyocytes.  
CRE elements are enriched in BIC-upregulated and TTX-downregulated genes. CREB has been 
found to bind to activity-induced genes such as Fos and Jun at baseline activity level and in 
response to TTX. However, CRE sites appear to require TATA boxes to recruit CREB-regulated 
transcription coactivator 1 (CRTC1) in response to activity or reduce CRTC1 occupancy in 
response to TTX. 151. CRE-containing promoters absent of TATA boxes, however, do not recruit 
CRTC1 and are not stimulus dependent. Therefore, examination of activity-dependent genes can 
include examination for the presence of CRE elements and differential TATA box presence. 
CREB is, however, recruited by neuronal activity to enhancer regions, suggesting enhancers may 
guide neuronal activity-dependent transcription. 151 
Synthetic biology approaches can illuminate some of the questions underlying alternative 
promoter selection. For example, fluorescent reporter genes under the control of drug-inducible 
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synthetic alternative promoters152 can be used to examine the interaction between inter-promoter 
distance and differential regulation, 5’ leader regulation, and the importance of cis and trans 
elements or coordinated cellular treatments (e.g. high vs. low activity states). In this way, 
questions of mechanism can be directly answered at the level of single-cells and cell population.   
To test these hypotheses on mechanism, alternative TSS usage can be assessed in cultured 
neurons treated with lentiviral knockdown of transcription factors, splicing factors and FACT 





The model of activity-dependent transcription and synaptic scaling is a useful tool to explore the 
interacting functions of chromatin regulators, and the interacting mechanisms of alternative 
promoter usage, alternative splicing, alternative 3’ ends, enhancer activation, and others. In this 
work, I demonstrated the utility of a nascent RNA method to detect more precisely the 
expression trends in the transcriptomes between high- and low-activity states. Nascent 
transcription analysis had the advantage of identifying with certainty that the effects analyzed 
came from transcriptional mechanisms.  
Interestingly, we discovered, as is the case with RAI1 chromatin binding and PDE2A promoter 
usage, times when shifts to either high or low activity states show similar changes compared to 
the baseline state. This suggests that the baseline state retains an identity beyond a midpoint 
between the two states, and requires a specific transcriptome in order to maintain its state. This 
perspective may help to unravel new mechanisms controlling synaptic scaling, LTP, and LTD, 
especially if all three activity states are simultaneously examined.  
Alternatively, our analysis with RAI1 underlines a link between neural activity-dependent 
transcription and circadian rhythms. The intersection between these two phenomena remains 
relatively unexamined in analyses of activity-dependent neuronal function, despite ample 
evidence of transcriptional regulatory mechanisms and protein pathways shared between them. 
The initiation of hyperactivity and inactivity may serve to synchronize neuronal cultures’ 
circadian clocks similar to zeitgeibers of light or eating in living animals. In this case, the 
cultures at baseline represent not a specific cellular state but a population of neurons with 
unsynchronized clocks. Therefore, any distinction between baseline state and inactivity or 
hyperactivity may be due to neurons at distinct timepoints in their circadian cycles. In this 
interpretation, RAI1 likely oscillates on the chromatin in a circadian manner, with peak 
occupancy at a time that does not correlate with 4 hours post TTX or BIC. Loss of RAI1, then,
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may push cells transcriptome towards not (only) an inactivity-like state, but a different circadian 
time.  Casting neuronal activity in terms of its effect on circadian time may reveal better how 
neuronal activity-dependent transcription and thus synaptic plasticity functions at the 
transcriptional level. Furthermore, expanding the set of enzymes that intersect with neuronal 
function and neurodevelopment, allows for an expanded toolbox of drugs that can be used to 
address neurodevelopmental disorders and sleep. A deeper understanding of circadian time and 
synaptic plasticity can also inform which compounds may impact either system with maximal 
efficacy and safety.   
While bulk analysis of diverse cellular populations obscures cell-specific changes, assessing 
correlations between genome-wide characteristics may allow the detection of interesting trends, 
as was the case with the discovery of alternative promoters and with Rai1-KD’s trend towards a 
TTX-like state. Small correlations may reveal the mechanisms of cell-subtype specific changes. 
This broad view can be augmented by a cell-type and single-cell approach. That is, the 
immunocytochemistry and electrophysiology used in this dissertation can be complimented by 
methods to isolate cell subtypes from bulk tissue/culture (e.g. INTACT), or single cell methods 
such as in situ hybridization, live-imaging, or single-cell sequencing methods.  
Genes associated with neurodevelopmental disorders allow us to identify pathways of interest 
that are relevant for cognition. For example, the striking sleep patterns of individuals with SMS 
bolster the hypothesis of RAI1’s interaction with circadian genes. Drawing more ties between 
human behavior and characteristics in a given monogenic NDD and the molecular and cellular 
functions of its associated gene will accelerate both our understanding of pathways and processes 




Appendix A.  Development of Low-Input DLAF RNA-seq Library Preparation Protocol 
The discovery of alternative promoter usage after activity shifts was possible due to abundant 
intronic reads from Bru-seq protocol. However, to profile mature RNAs, we needed to use an 
mRNA sequencing protocol. However, many conventional mRNA sequencing protocols deplete 
read coverage at the 5’ end of genes, making transcription start site identification difficult. The 
Direct Ligation of Adaptors to First-strand cDNA protocol developed in the Iwase lab actually 
enriches the 5’ end of genes 130. However, the protocol was developed for RNA inputs ~ 1-4 mg. 
Neurod6-Cre Ribotag immunoprecipitation of ribosome-associated RNAs from the visual and 
somatosensory cortices often yielded RNA mass <100 µg. Initial experiments using the original 
DLAF protocol resulted in poor library complexity and over-representation of adaptors. I aimed 
to adapt the DLAF protocol to achieve a shorter, more streamlined protocol that retained 
maximal RNA for robust sequencing results. 
Figure A-1. Effect of Post-Trizol Purification Method on RNA yield and integrity. Column Purification 




Examination of purification and RNA fragmentation steps 
After ribosome immunoprecipitation, RNAs must be separated from ribosomal proteins through 
Trizol phase separation. Since column purification can retain much RNA in the column, I first 
examined whether the critical purification step after Trizol phase separation was distinctly 
different between column purification and ethanol precipitation. Phase separated RNA from one 
whole-tissue sample was divided into 8 equal volumes and 4 replicates per purification method 
was tested and examined using Bioanalyzer RNA concentration and RNA integrity analysis. I 
found that while column purification and ethanol precipitation resulted in similar mean yields 
and RNA integrity numbers, column purification resulted in lower variability (Fig. A-1). 
Therefore, I proceeded with column purification as the standard method.   
Another critical step in library purification is RNA fragmentation, which determines the size of 
library fragments. Too long of RNA fragments fail to adhere to the Illumina chip, and too short 
of fragments prevent size-separation with adaptors, leading to adaptor contamination. Since my 
initial run of the DLAF protocol resulted in high adaptor proportions, I wanted to optimize the 
fragmentation protocol to the ideal RNA fragment length of ~200-300 nucleotides. First, I 
examined whether RNA fragmentation was concentration-dependent, as different samples may 
yield quite varying concentrations of RNA as input to the fragmentation step. I compared 
identical RNA diluted to 8 ng/µL, 2 ng/µL, and 0.8 ng/µL, and subjected it to fragmentation in 
high-magnesium Tris-HCl buffer for 4, 8, or 12 minutes. I found that there was little drastic 
difference in the efficacy of the fragmentation protocol for each concentration, suggesting RNA 
fragmentation is concentration-independent within this relevant range (Fig. A-2). However, 
when examining the time-dependence of RNA fragmentation, 12 minutes outperformed 8 and 4 
minutes, as there remained many high-molecular-weight, unfragmented RNAs in the 4 and 8 
minute samples. Therefore, I selected 12 minutes as the standard fragmentation time.   
Next, I tested the temperature dependence of RNA fragmentation. Using the same concentration 
of 8 ng/µL (400 ng total), I tested temperatures between 65 and 90°C. There was a clear 
increase in 200-400 nt size RNAs at 90° C, so I proceeded with this temperature. (Fig. A-3).  
69 
 
I then tested whether magnesium concentration was critical for RNA fragmentation. The current 
protocol stated the use of a commercial fragmentation buffer that contained 2.8 mM Mg2+.  I 
fragmented 8 ng/µL RNA for 12 minutes at 90 °C under Mg2+ concentrations ranging from 0.7-
5.5 mM. There was a clear shift in RNA fragment size above 1.4 mM Mg2+, including RNAs 
shorter than 200 nt, overlapping with the predicted adaptor length of 150 nt (Fig. A-4). This also 
explained the potential low yield in library size, as RNAs in this size range were likely to be 
























































































Figure A-2. Effect of Time and Concentration on Fragmentation. RNA at 0.8, 2, and 8 ng/µL show robust fragmentation 



























































































Figure A-3. Effect of Temperature on RNA fragmentation. Temperatures of 85-90°C show most robust fragmentation, 
while lower temperatures show remaining long RNA. 
5.5 mM  2.8 mM  1.4 mM  0.7 mM  
Figure A-4. Effect of Magnesium Concentration on RNA fragmentation. Magnesium Concentration greater than 1.4 µM 




Lastly, I tested the robustness of Ampure bead RNA purification to slight changes in protocol. 
There are many warnings that state that incubation time, bead drying time, and elution time are 
critical for efficient purification. Since during library preparation I handle many samples, this 
could be a source of variability, as different samples receive different times for each step. 
Therefore, I sought to determine critical factors of Ampure bead purification. I varied initial 
RNA: bead incubation time from 5-15 minutes; I varied dry time from 2 to 10 minutes (at which 
point the beads were very dry and light brown), and I varied elution time from 5 to 10 minutes. I 
used column purification of RNA as a control, which is known to yield lower amounts of RNA. 
Using 2 replicates for each sample, I found that surprisingly, all conditions showed similar yields 
(ranging from 90% yield to 70% yield) (Fig A-5). This is significant, but not as drastic as 
presumed. The long dry samples did have an overall lower yield than the short dry samples (Fig. 
A-6), but this was not drastic, especially as 10 minute dry time is an extreme length of time 
unlikely to occur even with dozens of samples. Other conditions did not show any evidence of 
being critical. Meanwhile, the column purification performed much worse, with only 10% yield 
(likely so low due to low 100 ng input). Therefore, going forward, small modifications to 
Ampure protocol are likely not to affect yield, excepting very long bead dry times.  
Lastly, I wanted to assess whether use of the more precise, but more time consuming Qubit was 
superior to the Nanodrop. I therefore measured 16 samples in both Nanodrop and Qubit and 
observed correlation between measurements (Fig. A-7A). However, there was a consistent trend 
in Nanodrop measuring higher concentrations of RNA by ~20% (Fig. A-7B). Therefore, Qubit 
was used to determine the initial concentrations of RNA in the subsequent low-DLAF input 




Figure A-5. Ampure purification protocol is robust to small changes in protocol 
 
Figure A-6. Effect of Dry Time on RNA Yield in Ampure purification. Extra-long dry time (15 min) shows minor 





Testing Low-DLAF protocol with different RNA input mass 
I therefore ran the adapted Low-DLAF protocol with RNA inputs of 4 µg, 1 µg, 250 µg, and 62.5 





































Figure A-7. Comparison of Nanodrop and Qubit measurements of RNA concentration in water. Sample concentrations 





assigned to mouse mm9 genome. Lower input RNA had less adaptor contamination, likely as 
total adaptor mass was reduced for lower RNA input. However, there was a clear increase in the 
percentage of ribosomal reads in the low-input samples, suggesting these may be preferentially 
retained and amplified, and more stable in lower concentrations than non-ribosomal RNAs. 
However, the genes that were uniquely mapped were of similar percentage, and the overall 
percentage of good reads (those uniquely assigned to one genomic location in the mm9 genome) 
decreased only from 53% to 48% from 4 µg input to 62.5 µg input. Similarly, the genes mapped 
to mm9, ~70% were assigned to gene bodies (Fig. A-8).  
Interestingly, while there were a similar number of reads input from each sample, the median 
read count/gene was significantly higher for higher RNA input 4 µg sample. This suggests there 
were a few genes with an overabundance of reads in the lower samples (e.g. contaminating 
ribosomal RNAs). This same trend was seen examining the read counts at TSS region (TSS + 
1kb downstream (ds)). However, even low input retained similar coverage at TSS compared to 
total gene read count, suggesting the 5’ end coverage is not disproportionately compromised with 
low RNA input.  
Lastly, I examined the correlation of read counts across the gene or TSS region between the 4 µg 
input and lower inputs. Predictably, the rho correlation was highest for 250 ng input, and lower 
for lower inputs (Fig. A-10). However, there was a clear positive correlation across all inputs 
excepting the negative 0 input control.  
Discussion 
These data give evidence that although there is a significant reduction in quality reads/gene or 
reads/TSS region for each sample, much lower input samples can be assessed, although deeper 
sequencing and removal of ribosomal reads may be necessary to achieve quality differential 






































4 ug 10,152,461 1,577,558 16% 5915751 58% 352961 6% 135358 2% 5427432 92% 53% 3758221 3.7582 69.24% 37% 1.8425
1 ug 10,940,881 1865642 17% 5620378 51% 816391 15% 105369 2% 4698618 84% 43% 3373802 3.3738 71.80% 31% 2.1283
250 ng 11,062,037 218,576 2% 6852978 62% 1238187 18% 187932 3% 5426859 79% 49% 4094342 4.0943 75.45% 37% 1.8427
63ng 9,413,143 840,291 8% 5608004 60% 1025812 18% 164268 3% 4417924 79% 47% 3345677 3.3457 75.73% 36% 2.2635

















































Reads Assigned to 
Gene (M) 
Figure A-8. RNA Input’s effect on filtered and unfiltered read counts.  
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Raw Counts Per Gene Raw Counts Per TSS (1kb ds) 
Figure A-9. RNA Input’s effect on normalized read counts 
Figure A-10. Mapping reads to gene and TSS regions from low-input samples 
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Appendix B. Materials and Methods  
Primary neuron culture and shRNA-mediated Rai1-KD 
The cortices and hippocampi from E18.5 mouse pups were pooled into biological replicates with 
identical female-male ratios. Sex of the pups was determined by PCR using primers for the ZFY 
gene (Table S6). Primary culture of neurons was carried out as previously described 132 153. 
Briefly, dissociated tissues were plated at 4 million cells/6 cm poly-D-lysine-coated plate 
(Sigma) grown in Neurobasal Media supplemented with B27 (Gibco, #17504044). No mitotic 
inhibitors were added, allowing the growth of non-neuronal cells. Half the culture medium was 
freshened every 3-5 days. On DIV 14, cells were infected with lentiviral shRNA as previously 
described 153. Lentivirus were generated using co-transfection into HEK-293t cells of psPAX2 
(Addgene, 12260), pMD2.G (Addgene, 12259) and pLKO plasmids containing shRNA against 
Rai1 untranslated region (Rai1-shRNA #1: Sigma, TRCN0000124984) or coding region (Rai1-
shRNA #2: Sigma, TRCN0000328334) or scramble shRNA (Sigma, SHC202). For Bru-seq 
experiments, we used SHC202 and Rai1-shRNA #1. For electrophysiology, we used SHC202, 
Rai1-shRNA #1 and #2, whose target sequences are identical between mouse and rat. The 
conditioned media containing lentiviruses was collected, concentrated with Lenti-X concentrator 
(Takara, 631232), and resuspended in Neurobasal medium, and stored at −80°C. The titer of 
lentivirus was determined by survival of transduced 293 cells under puromycin and a comparable 
amount of virus that result in >90% survival of infected neurons was used for all biological 
replicates. Puromycin was not added to cultured neurons for experiments.  
Network activity alterations and Bru-seq experiments 
On DIV17, cells were treated with bicuculline-methiodide (Abcam, ab120108, 20 µM), TTX 
(Tocris, 1069, 1 µM), or vehicle (sterile water), for 4 hours. 3 hours and 40 minutes post 
treatment, bromouridine (Bru, Sigma, dissolved in PBS) was added to cultures at 2 mM final 
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concentration. Cultures were harvested in Tri-reagent BD (Sigma, T3809) and frozen 
immediately. RNA was purified using phenol-chloroform extraction and isopropanol 
precipitation, treated with DNAse I (NEB) then fragmented by high-magnesium, high 
temperature incubation. From 1 µg of total RNA, enrichment of Bru-containing RNA and library 
preparation were performed as previously described 44,45 with minor modifications. We designed 
custom adaptors (Table S6) which were directly ligated to the 3’ ends of RNA using RNA ligase 
1 (NEB Cat. No. M0437) and truncated RNA ligase KQ (NEB M0373). Bromouridine-labeled 
RNAs were immunoprecipitated using anti-BrdU antibody (Santa Cruz Biotechnology, sc-
32323). Enriched RNAs were reverse transcribed using a primer complementary to the RNA 
adaptor (Table S6). Adaptor duplexes with 5- or 6-base pair random nucleotide overhangs were 
ligated to the 3’ end of the cDNA (Table S6). The cDNA libraries were amplified using primers 
that carry Illumina indices, then 180-400 bp DNA fragments were isolated using by an agarose 
gel. The nucleotide sequences of primers used for library amplification are found in Table S6. 
The libraries were subjected to single-end 50-bp sequencing using Illumina HiSeq 2000 
platform. We performed 2 to 3 biological replicates for all drug treatment and knockdown 
conditions.  
Sequencing data analysis 
After confirming the quality of sequencing data by FastQC, reads were mapped to mm9 
reference genome using Bowtie2 154 and annotated with Tophat2 155. Adaptors were trimmed 
using BBDUK (http://jgi.doe.gov/data-and-tools/bb-tools/), when 2-30 bp on the left of the read 
matched the predicted adaptor (k=30, mink=2, minlength=15, hdist=1). Bru-seq signals were 
quantified by FeatureCounts 156. We excluded Rn45s, Lars2, Rn4.5s, Cdk8, Zc3h7a and the 
mitochondrial chromosome to avoid counts of over-amplified genes that may skew RPKM 
normalization. DE-genes were identified using DESeq2 46 using the same parameters for the Bru-
seq data and three published mRNA-seq datasets of neuron culture and Rai1-KO mice 2,21,43. We 
also used DESeq2 to calculate RPKM expression values across the entire genic regions, 
including introns. Gene ontology was examined using RNA-Enrich 80. Significance cutoff for 
reporting Sig-genes was an unadjusted p value< 0.05. We only presented GO terms that contain 





To validate Rai1-KD in mouse forebrain neuron culture, Rai1-KD and control cultures were 
harvested at 3 days after lentiviral transduction and subjected to Western blot analysis as 
described previously 132. RAI1 antibodies were generated by immunizing rabbits with a 
synthesized RAI1 peptide (aa 28 to 42, ENYRQPGQAGLSCDR, Thermo Fisher Scientific), 
followed by affinity purification using the peptide as the affinity ligand (Thermo Fisher 
Scientific). Anti-PCNA antibody (Santa Cruz sc-56, 1:1000) was used for a loading control. For 
analysis of RAI1 level during activity shifts, the cortices from E18.5 rat pups were dissected, 
dissociated, and plated at 700,000 cells/well in a PDL-coated 6-well dish. Neurons were grown 
in Neurobasal/B27 medium for 14 DIV. Vehicle (1% water), TTX (1 µM) or BIC (20 µM) were 
added to the culture and cells were harvested with a 1:1 mixture of 2X Laemmeli buffer 
(BioRad, 1610737, 1:20 beta-mercaptoethanol) and radioimmunoprecipitation assay (RIPA) 
buffer supplemented with 50 mM BGP and 1 mM Na3VO4.  Protein samples were boiled for 10 
minutes at 100°C. 10-15 μg of each sample was loaded per lane, separated by 7.5% SDS-PAGE, 
and transferred onto PVDF membrane (Millipore IPVH00010). Membranes were then blocked 
with 5% skim milk or 3% blotting-grade blocker (BioRad 1706404) for 1 hr, probed overnight 
with the following primary antibodies diluted in 3% BSA (Fisher Scientific BP1600): RAI1 
(1:1000), beta-actin (Sigma A5441, 1:20,000). Horseradish peroxide (HRP)-conjugated 
secondary IgG antibodies (EMD Millipore AP132P or AQ160P) were also diluted in 3% BSA, 
and the HRP signal was developed with various chemiluminescent substrates from Thermo 
Fisher Scientific (34080 or 34095) and Li-COR Biosciences (926-95000). Protein band intensity 
was visualized and quantified in the linear range using LI-COR C-Digit and Image Studio 
software. Results were compared using one-way ANOVA.  
Immunocytochemistry 
Two biological replicates of forebrain neuron cultures were obtained from E17.5 mouse 
embryos. On DIV19, they were fixed with 4% paraformaldehyde in 16% sucrose/PBS, 
permeabilized with 0.25% Triton-X in 1X PBS, blocked for 30 minutes with 10% bovine 
albumin serum (Sigma A2153), and overnight incubation of antibodies in 3% BSA at 
4°C.Primary antibodies used in the study are following. anti-NeuN (EMD Millipore, MAB377, 
1:1000), anti-GFAP (NeuroMab N206A/8, 1:1000), anti-MAP2 (EMD Millipore, AB5543, 
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1:1000), anti-OLIG2 (EMD Millipore, AB9610, 1:1000), anti-CD11b (Abcam, ab133357, 
1:500), anti-GAD67 (Santa Cruz, sc-5602, 1:1000). Secondary antibodies (Invitrogen Alexa 
Fluor 488, 555, or 647) were applied for 45 min at room temperature. Fluorescence images were 
acquired using an Olympus BX61 fluorescence microscope (60X oil-immersion lens) and 
CellSense software. Immunoreactivity was quantified semi-automatedly using a custom ImageJ 
script after confirming specific staining by visual inspection. 
Electrophysiology 
All animal use followed NIH guidelines and was in compliance with the University of Michigan 
Committee on Use and Care of Animals. Dissociated postnatal (P0-2) rat hippocampal neuron 
cultures were prepared as previously described (Henry et al., 2012). Neurons were transfected 
with 1.0 µg of either non-targeting sh-RNA (sh-Ctrl) or Rai1-shRNA at DIV 12. For the rescue 
experiments RNAi resistant Rai1 expressing plasmids or its empty vector was co-transfected 
with the above sh-RNA expressing plasmids.  For the Pde2a experiments, empty vector or mouse 
Pde2a constructs were transfected. Transfections were performed using CalPhos Transfection kit 
(ClonTech) or Lipofectamine 2000 (ThermoFisher Scientific) according to the manufacturer’s 
protocols. All experiments were performed 48 hours after transfection. To induce synaptic 
scaling, neurons were treated with either 1 µM TTX, 10 µM bicuculline or vehicle for 24hr prior 
to recording. mEPSCs were recorded from a holding potential of – 70 mV with an Axopatch 
200B or Multiclamp 700B amplifier from neurons bathed in HEPES buffered saline (HBS) 
containing: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 mM 
HEPES (pH 7.4) plus 1 µM TTX and 10 µM bicuculline; mEPSCs were analyzed with 
Synaptosoft MiniAnalysis software. Whole-cell pipette internal solutions contained: 100 mM 
cesium gluconate, 0.2 mM EGTA, 5 mM MgCl2, 2 mM ATP, 0.3 mM GTP, 40 mM HEPES (pH 
7.2). Statistical differences between experimental conditions were determined by unpaired 
Student’s t-tests (Fig. 6) or one-way ANOVA followed by post-hoc Fisher’s LSD test (Fig. 3).  
Surface GluA1 expression analysis 
Surface GluA1 staining was conducted as previously described with slight modification (Henry 
et al., 2012). On DIV12, rat cultured hippocampal cells were infected either with lentivirus 
carrying sh-Ctrl or sh-Rai1 as described above. After 72 hours of incubation, cultured cells were 
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live-labeled with rabbit anti-GluA1 antibody (10 µg/ml, EMD Biosciences) for 20 min at 37°C, 
fixed with 2% paraformaldehyde, and further labeled with mouse anti-PSD-95 (EMD Millipore, 
MAB1596, 1:1000). Goat anti-mouse Alexa 488 and Goat anti-rabbit Alexa 555 secondary 
antibodies (Abcam, 1:500) were applied for 60 min at room temperature to visualize PSD-95 and 
GluA1 staining. Images of PSD-95 and GluA1 were aquired using an inverted Olympus FV1000 
laser-scanning confocal microscope using a Plan-Apochromat 63 X /1.4 oil objective. Then, 
synaptic GluA1 was defined as a particle that occupied > 10% of the PSD-95 positive area, and 
the average integrated intensity of synapatic GluA1 was calculated using a custom macro for 
ImageJ. Statistical differences between experimental conditions were determined by unpaired 
Student’s t-tests. 
Culturing on MEAs and Single Unit Recordings 
Dissociated postnatal (P0-3) rat hippocampal neurons were plated onto sterile multi-electrode 
arrays chips (MEAs) (60MEA200/30IR–TI; Multichannel Systems, Reutlingen, Germany) at a 
density of ~350 cells/mm2.  MEAs were coated with 0.05% polyethyleneimine and laminin (1 
µg/µL). MEAs were transferred to the incubator for at least 3 hours to allow for cell adhesion. 
Once adhered, media was added to each MEA to achieve a total volume of 1 ml per MEA. Media 
used was composed of Neurobasal Plus Medium with 1X B-27 Plus supplement, 1X GlutaMax 
and 50 U/ml of Pen/Strep (ThermoFisher, Waltham, MA). MEAs were covered with a gas 
permeable, ethlylene propylene membrane (MEA-MEM, Multichannel Systems, Reutlingen, 
Germany). Half volume media exchanges were done every 3-4 days. We evaluated the health of 
the neuronal cultures on DIV 10. Cultures that exhibited spontaneous spiking activity on ≥ 10 
electrodes were considered healthy and included in the study. On DIV 11, neurons were 
transfected with lentivirus encoding scrambled or Rai1- by performing a half-media change. On 
DIV 14, Local Field Potential (LFP) recordings were acquired at 20 kHz using a MEA2100-
System (Multichannel Systems, Reutlingen, Germany). MEA chips were secured to the 
headstage of the amplifier and maintained in a controlled environment (37°C, 5% CO2) for the 
duration of the recording. Prior to recording, we left the MEAs undisturbed for eight min to 
allow for acclimation after handling. Spontaneous activity was captured during five min epochs.  
Data was imported into MATLAB (MathWorks, Natick, MA) and analyzed using custom written 
scripts. The LFP signal was high pass filtered at 100 Hz using a Butterworth filter. Spikes were 
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detected using amplitude thresholds set at five times the root mean square of the noise. Neuronal 
units were identified by spike sporting using principal component analysis of the detected spike 
and manually identifying clusters. A spike was defined by the signal 1 ms before the peak to 3 
ms after the peak. The inter spike interval was defined as the time between two adjacent spikes. 
Mean firing frequency was calculated by dividing the total number of spikes detected for each 
neuronal unit by the recording duration. Statistical analyses were done in MATLAB and 
GraphPad Prism (GraphPad Software, San Diego, CA). 
 RAI1 ChIP-seq 
ChIP was performed as previously described 157. We dissociated E18 mouse forebrains and 
culture them for 14 DIV, infected with lentivirus containing sh-Rai1 #1 or sh-Ctrl. On DIV17, 
we treated cultures with 2 M TTX, 20 BIC, or water vehicle for 4 hours, harvested the 
cells, fixed with 1% formaldehyde in HBSS for 30 minutes at room temperature, and prepared 
chromatin samples. We digested chromatin first with MNase for 20 min at 25°C. We then 
spiked, Drosophila chromatin, which contains fly-specific histone variant H2Av (Active Motif 
Cat. No.  53083). Samples were then further sheared by sonication using Qsonica Q800R3 
at 70% amplitude 15 sec pulse with 20 sec interval for 30 min (total time: 70 min). The 
antibodies applied were the abovementioned anti-RAI1 polyclonal and anti-Drosophila H2Av 
antibodies (2.5 µg/sample). Antibody-antigen complex that formed at 4°C overnight were 
precipitated with Dynabeads Protein A/G mixture (1:1, Invitrogen 10001D, 10003D). We 
isolated the pulled down DNA and made sequencing libraries with NEBNext reagents (E7645S) 
and sequenced them on the Illumina HiSeq4000 platform to generate 50 bp single-end reads.  
Raw reads were demultiplexed and filtered according to the standard Illumina analysis pipeline.  
Reads from sequencing libraries were then mapped to the mouse (mm9) and fruit fly (dm6) 
genome assemblies using Bowtie1 158 allowing up to 2 mismatches.  Only uniquely-mapped 
reads were used for analysis. We used MACS2 (version 2.1.0.20140616, FDR < 0.01) to identify 
RAI1 peaks using pooled input samples as a control 159. For visualization in the UCSC browser, 
bigwig files were generated with coverage normalized using the number of mapped reads to the 
Drosophila genome (reads mapped per reference genome per million reads) 160,161. ChIPseeker 
162 annotated RAI1 peaks to promoters, genic, or intergenic regions. We integrated following 
publically available epigenomic datasets: DNase I hypersensitive sites (DHS) of whole brain 
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samples (E14.5: GSM1014197, 8 week adult: GSM1014151), H3K4me1: whole brain (8 week: 
GSM769022, E14.5: GSM1000096), H3K4me3: whole brain (8 week: GSM769026, E14.5: 
GSM1000095): H3K27ac (E14.5 whole brain: GSM1000094, 8 week forebrain: GSM3666438): 
and H3K27me (E14.5 H3K27me2 whole-brain: GSM1000143, 8 week H3K27me3 forebrain, 
GSM3666437). Putative transcriptional enhancers were defined as DHS-positive RAI1 peaks (± 
500 bp) that overlap with H3K4me1 but not H3K4me3.  
Alternative promoter analysis 
A custom pipeline using bedtools (v2.25.0) 163 and R (3.6.1) was developed to discover genes 
with alternative TSS usage (accessible at https://github.com/pmgaray). Briefly, coordinates for 
H3K4me3 broadpeaks in mouse cortical neuron cultures were selected if they overlapped with 
the coordinates of Refseq or GENCODE mouse mm10 annotated TSS. This list of promoter 
regions was then intersected with gene bodies to attribute gene name to each putative promoter. 
These were converted to TSS Regions and Featurecounts (1.5.0) 156 was used to attribute read 
counts to each TSS region. TSS regions with RPKM <0.003 and RPM < 1 were filtered out 
based on the point of maximum curvature of ranked RPKM/RPMs (akmediods:::elbowPoint, 
github.com/agentlans) . Genes with more than one TSS region that passed these thresholds were 
counted as multiple promoter genes. The most downstream promoter region was defined as the 
reference region. Raw read ratios for each replicate were calculated by dividing read count of 
upstream TSS regions by the read count of the downstream reference region. A linear model was 
constructed using the default R lm command; QR decomposition solution to linear least squares 
problem (lm(value ~ Treatment, data=Array of ratios)). TTX, vehicle, or BIC were used as the 
dummy variable to determine if a correlation existed between treatment and the relative ratio of 
upstream and downstream promoter usage. P-values for the hypothesis test Correlation=0 were 
adjusted by Benjamini-Hochberg adjustment (p.adj, method=”BH”) and a cutoff of 0.1 was 
selected to define ADDUP genes. 
In vivo validation 
Mice were raised in 12 hour/12 hour light dark cycles until post-natal day 60. Mice were 
maintained in a 24 hour dark cycle, and then half the mice returned to light for 4 hours. Mice 
were sacrificed, and the visual cortex and somatosensory cortices of each hemisphere dissected. 
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Brains were dissociated, cells lysed, and tagged-ribosomes immunoprecipitated. Resulting 
RNA/ribosome mix was resuspended in Trizol.  
RNA-seq Library Preparation 
RNA was prepared according to an adapted version of the DLAF protocol 130 to accommodate 
lower input mass. NEBNext rRNA-depletion kit was utilized with 10 ng of RNA as input.  
RNA-seq Sequencing and Analysis 
Reads were mapped to the mouse mm10 genome by STAR (2.5.3a). BED file of First exons was 
created by taking annotated Refseq mm10 transcripts, selecting out the first exon, and 
intersecting with gene names in order to attribute exon number and gene name to each exon. 
Featurecounts was used to quantify read count/exon. Exons with counts >100 reads were 
selected. Potential genes were examined visually to corroborate changes. Gene ontology 
enrichment was analyzed with WebGestalt (2019) 164 
Immunocytochemistry and Image Analysis 
Two biological replicates of cortex and hippocampus from E17 mouse pups were collected and 
plated onto PDL-coated glass coverslips. At DIV 14 they were infected with lentiviral shRNA. 
On DIV19, they were fixed with 4% paraformaldehyde in sucrose/PBS. Slips were stained with 
anti-NeuN, anti-GFAP, anti-Map2, anti-Olig2, anti-microglia, anti-Vglut, anti-Vgat and anti-
Pdgrfa. Antibody was incubated overnight at 4 °C. Secondary antibodies (Alexafluor 488, 555, 
and 647) were applied for 45 minutes at room temperature. Slips were affixed with Prolong Gold 
with DAPI. Slips were imaged using a Nikon X microscope and Olympus CellSense software at 
20X magnification. Cells were quantified using a custom ImageJ script. 
Data Availability 
Sequencing data generated for this study have been submitted to the NCBI Gene Expression 
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